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Abstract
Why are they Wrong: Exploring surrogates’ accuracy when predicting patient treatment
preferences
Rachael Spalding
Surrogate decision making is common in medical settings, particularly regarding
treatment decisions for patients at end-of-life. When making decisions on behalf of patients,
surrogates are most often encouraged to use the substituted judgment standard and make the
decision that the patient would make if he or she were able to express a choice. A significant
body of research, using patient-surrogate pairs and hypothetical vignettes, has documented that
surrogates tend to inaccurately predict patient preferences when making these decisions
(Shalowitz et al., 2006). This results in treatment decisions that do not match what the patient
would have selected. Various factors that may influence surrogates’ predictive accuracy have
been proposed, but no empirical examination of the relation between such factors and accuracy
has yet been conducted. This exploratory study investigated whether certain intrapersonal and
interpersonal variables predicted surrogates’ accuracy, using patient-surrogate dyads and an
online survey methodology employing hypothetical treatment decision vignettes.
One-hundred-and-fifty-four adults over age 45 were recruited from Amazon Mechanical
Turk and the West Virginia University faculty and alumni listserv to complete an online survey
as the “patient” and indicate the treatment option they would prefer in a variety of treatment
decision scenarios. Patients then shared a link to a similar online survey with an adult from their
life who would likely serve as their surrogate decision maker and make decisions on their behalf
in the event of incapacitation. Therefore, 154 patient-surrogate pairs, or 308 total participants,
were recruited. Surrogates completed the decision scenarios using the substituted judgment
standard, indicating the treatment preference that they thought the patient would prefer. All
participants completed self-report measures of the selected interpersonal and intrapersonal
variables. Patients and surrogates were compensated with an Amazon gift card for their
participation.
Consistent with prior research, the current study found that surrogates are generally poor
predictors of patient preferences when selecting interventions on decision vignettes. In terms of
intrapersonal variables, surrogates’ accuracy when predicting preferences was positively
correlated with levels of empathy and religiosity. Surrogates’ levels of trust in the medical
profession were also positively correlated with accuracy.
When considering their partners’ values, surrogates who reported greater perceived
similarity to their patients regarding end-of-life values and who perceived their partners as more
reluctant to burden others tended to be more accurate. Pairs who reported high discrepancies in
perceived similarity on end-of-life values (e.g., the patient reported low similarity while their
surrogate reported high similarity, and vice versa) were those in which surrogates were better
predictors of treatment preferences. When these significant correlates were included in a multiple
linear regression analysis predicting accuracy, the predictive model was significant (F(6) = 3.03,
R2 = .12, p = .008); however, none of the variables appeared as unique predictors.
Examination of accuracy for individual decision vignettes provided further evidence that
surrogate medical decision making varies based on the type of treatment decision that is being
made, as the variables predicted accuracy for certain decisions when examined individually. An
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exploratory analysis investigated the predictive role of the variables with respect to surrogates’
selection of interventions for patients on the decision vignettes. The variables significantly
predicted surrogates’ selection of intensive interventions, F (16) = 2.28, R2= .24, p = .006. Of the
predictor variables, the only unique predictor was COVID-19-related anxiety, such that
surrogates with greater anxiety about COVID-19 tended to select intensive treatments for
patients. Findings from this exploratory study can inform the development of more targeted
decision-making interventions to improve surrogates’ accuracy. Providers may also attend to
certain variables to facilitate surrogates’ treatment selection and their ability to execute their
decision-making role, particularly during the stressful context of the COVID-19 pandemic.

SURROGATES’ ACCURACY
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SURROGATES’ ACCURACY
1
Why Are They Wrong? Exploring surrogates’ accuracy when predicting treatment preferences
Decisions about medical treatment at end-of-life are some of the most challenging that a
patient can face. End-of-life care has become a timely topic in the United States, with survey
data revealing increased concerns for maintaining personal control over the circumstances of
one’s death, in addition to greater fears of pain and dependency at end-of-life (Blendon, Szalay,
& Knox, 1992). These issues have also risen in pertinence recently amidst the coronavirus
(COVID-19) pandemic, which has brought critical care services and end-of-life care to the
forefront of public consciousness (Pattison, 2020). Public health and policy initiatives have also
drawn attention to this area as a result of health initiatives stemming from the Patient SelfDetermination Act (Baker, 2002) that promote completion of advance directives outlining endof-life care preferences. Decisions about end-of-life care are unique from other types of medical
decisions, since when death is imminent the main goal of treatment may shift from one of
quantity to quality, such that providing comfort and reducing pain are prioritized over prolonging
life. For instance, in the case of a patient who has lost the ability to breathe independently for an
extended period, a decision for the patient may arise regarding whether to be placed on
mechanical ventilation or to withhold ventilation and focus on providing comfort care measures
for the remainder of his or her life.
Surrogate Decision Making: An Overview
Decisions about end-of-life medical treatment are often made by individuals other than
the patient. This occurs when a patient is unable to express a choice on their own behalf or is
otherwise considered incapacitated and no formal documentation (e.g., an advance directive)
exists that explicitly states the patient’s preferences regarding a particular treatment decision.
This situation occurs among nearly half of hospitalized older adults (Torke, Sachs, & Helft,
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2014) and close to 50% of all patients considered to be at end-of-life (Tejwani et al.,
2013). In these cases, treatment decision making is deferred to the patient’s surrogate decision
maker (an adult over age 18 hereafter referred to as a “surrogate”). The surrogate is usually a
family member or close friend who the patient has identified in advance, most often through a
durable power of attorney for medical decisions, which gives written authorization for a
specified person to make medical decisions on the patient’s behalf.
If such documentation does not exist, or if the person identified is unwilling or unable to
serve in the role, decision-making authority for the patient is deferred to another individual based
on the state’s legal hierarchy. Under this hierarchy, members of the patient’s family fall in a
priority list of potential surrogates who may be consulted on behalf of the patient. Higher priority
rankings are generally given to more immediate family members. In most states, the hierarchy
order is as follows: a spouse (unless divorced or legally separated), an adult child, a parent, and
an adult sibling (American Bar Association, 2019). The hierarchy list extends to include more
distant family members and, in some states, close friends. If the patient has no living family
members or close friends who are able to serve (as in the case of an “unbefriended” older adult;
Farrell et al., 2017), another non-related individual (e.g., a court-appointed legal guardian) is
designated by the patient’s treating physician. The chosen surrogate in these situations cannot be
the patient’s current health care provider or an employee of the patient’s primary health care
facility. Best-practice guidelines exist, such as those posed in a position statement by the
American Geriatrics Society (Farrell et al., 2017), to guide those who are tasked with making
medical decisions in these cases.
Surrogate Decision Making and the Issue of Accuracy

3
When making medical decisions, surrogates are most often encouraged to use the
substituted judgment standard, which specifies that a surrogate should make decisions in
accordance with what the patient would have selected if he or she were able to express a choice
(Tejwani et al., 2013). Other standards for medical surrogate decision making exist, including the
best interest standard, which encourages decision making based on established community
norms, and the life narrative approach, which advocates for making decisions within the context
of a patient’s broader values and life story. The question of whether the decision made by the
surrogate agrees with the decision that the patient would have made therefore only emerges in
relation to the substituted judgment approach. Subsequently, this approach raises surrogate
decision-making accuracy as an issue, regarding whether surrogates adequately predict patient
preferences through their decisions. Although criticisms of the substituted judgment standard
have been raised regarding its practical utility and the extent to which it can be feasibly executed
by surrogates (Bailey, 2002; Torke, Alexander, & Lantos, 2008), this standard is still considered
the most complete option and is currently employed in most states (Tejwani et al., 2013).
Copious research to date suggests that surrogates are often inaccurate when predicting
patient preferences. In a systematic review of the surrogate decision-making accuracy literature,
Shalowitz (2006) concluded that individuals serving as surrogates predict patient preferences
only slightly better than chance, with 68% accuracy on average. Additional evidence reflects a
particularly strong tendency for surrogates to “overtreat” and select a more invasive, lifesustaining treatment than what the patient would want (e.g., Li et al., 2007).
Variables Related to Surrogate Decision-Making Accuracy
While several studies of surrogate decision-making accuracy and theoretical models (e.g.,
Marks & Arkes, 2008; Torke et al., 2008) have proposed factors that may impede surrogate
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accuracy when identifying patient preferences, no research has yet formally investigated the
extent to which these factors predict surrogates’ accuracy. The variables that have been
suggested to date derive from both intrapersonal and interpersonal domains. The following
sections describe the variables that have been most frequently proposed to date, as determined by
the relative frequency with which they have appeared in empirical and theoretical discussions of
surrogate decision-making accuracy. These variables, and others, were subsequently investigated
by the current study, which was exploratory in nature and broad in scope.
Surrogate Intrapersonal Variables
Emotions and Decision Making. The interplay between emotions and decision making
has been the subject of considerable empirical attention, with evidence indicating that strong
emotions can affect cognitive processes (Forgas 1995), including the manner in which one
estimates value (Pham, 2007) and risk (Loewenstein, Weber, & Welch, 2001). Experiencing
strong emotions also appears to increase one’s reliance on mood-related cues as a source of
information in the moment of decision making (Schwarz & Clore, 1996). Evidence from
neuroscience research involving patients with lesions to the ventromedial cortex, the area of the
brain responsible for interpreting emotion-related signals, also supports the notion that
information processing operates on an emotional level that plays a considerable role in decision
making (Bechara, 2004). Behavioral economics investigations of the “risk-as-feelings”
hypothesis, which posits the importance of affect in decision making, shows that emotional
reactions to risky situations, such as anxiety, can ultimately drive decision-making behavior by
disrupting one’s ability to more logically assess risks (Loewenstein et al., 2001). Specifically, the
uncertainty surrounding risky situations can stimulate informational processing biases related to
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threat, which prompt risk-averse decision-making tendencies that seek to maximize safety and
certainty (Kahneman & Tversky, 1984; Maner et al., 2007).
The experience of negative emotions may also affect one’s preferred role when making
decisions. Interestingly, one’s decisional style, or preferences for personal involvement when
making decisions, appears stable. That is, individuals’ preferences do not appear to vary
significantly if they experience increases in negative emotions like depression or anxiety
(Petersen, Sherman-Slate, & Straub, 2003). However, among patients (Brown et al., 2002) and
relatives (Anderson et al., 2009) who are asked to make medical decisions on behalf of
themselves or a loved one, those who meet clinical criteria for anxiety or depressive disorders
tend to prefer more passive decision-making roles.
Anxiety and Decision Making. A preponderance of evidence across fields, including
theoretical and empirical endeavors, suggest that experiencing anxiety can significantly alter
one’s decision-making performance (Hartley & Phelps, 2012). For instance, neuroscience
research (Somerville et al., 2004; Wager et al., 2008) indicates that higher trait-level anxiety and
clinically significant anxiety symptoms are associated with increased amygdala activation and
decreased engagement of areas of the prefrontal cortex that are responsible for logically
appraising risks and benefits. These patterns of neural activation can reduce one’s ability to
comprehend information relevant to a decision-making situation and produce attentional biases
that focus attention on negative choice options (Cisler & Koster, 2010). Increased anxiety can
therefore manifest behaviorally as a greater tendency to avoid negative outcomes, regardless of
the magnitude of potential gains, when making decisions (Hartley & Phelps, 2012).
Depression and Decision Making. Similar to anxiety, depression is a psychological
factor that has received considerable attention with regard to its influence on decision-making
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abilities (Paulus & Angela, 2012). Research (Murphy et al., 2001) indicates associations between
clinically significant depressive symptoms and impairments in cognitive function, specifically
executive functioning abilities involved in decision-making processes. This evidence has raised
questions in the field of decision-making capacity as to whether the executive functioning
abilities of clinically depressed individuals could be impaired enough to warrant concerns of
incapacitation. According to a recent systematic review, current evidence indicates that severe
depressive symptoms can impair decision-making capacity, particularly by impeding the extent
to which one appreciates the importance of decision-relevant information (Hindmarch, Hotopf,
& Owen, 2013). Moreover, as Grisso and Appelbaum (1995) summarize in a review of the
literature, depressive symptoms reduce one’s abilities to comprehend information in general,
which can produce less-informed and lower-quality decisions.
Anxiety, Depression, and Surrogate Medical Decision Making. The role of emotions
in decision making is particularly important to consider in medical contexts. Medical decisions
are associated with a high degree of perceived uncertainty, as reported both by providers when
engaging in clinical decision making (Beresford, 1991) and by patients themselves when making
personal treatment choices (Curley, Eraker, & Yates, 1984). The considerable pressures of risk
and uncertainty when making medical treatment decisions can render patients more susceptible
to the influence of their emotions (Kaplan & Frosch, 2005). For instance, cancer treatment
decisions have been conceptualized as requiring patients to manage fears across multiple
domains, including treatment side effects, the experience of the disease itself, and the burden
placed on potential caretakers and loved ones (Ellis & Ferrer, 2018; Ferrer, Green, & Barrett,
2015). Several models of medical decision making have therefore evolved to account for the
influence of emotions (e.g., Leventhal & Patrick-Miller, 1993; Schneider & Schneider, 1998). In
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particular, Power, Swartzman, and Robinson’s (2010) cognitive-emotional decision-making
model conceptualizes the act of making a medical decision as a coping mechanism for patients to
manage the negative emotions associated with confronting potential threats to their health. In
accordance with this model, a patient may be motivated to make a medical decision to eliminate
the anxiety and uncertainty preceding the decision, as they consider potential treatment options
and prognoses. As a result, Power and colleagues (2010) suggest that patients may be apt to
make hasty decisions with minimal consideration as a means of improving their emotional
experience more quickly.
These findings from the patient medical decision-making literature can inform research
on surrogate decision making, as negative emotions can impair surrogates’ abilities to understand
and remember detailed, complex medical information pertaining to the patient (Engel et al.,
2009). Qualitative and quantitative examinations of the surrogate decision-making experience
reveal that the experience of serving as a surrogate can evoke negative emotions, such as posttraumatic stress symptoms (Azoulay et al., 2005) and greater overall self-reported stress, anxiety,
and depressive symptoms (Wendler & Rid, 2011) following instances of treatment decision
making.
For surrogates, the experience of making high-stakes medical decisions regarding lifesustaining treatment on behalf of a significant other can provoke anxiety (Powell, 1999). Family
members who serve as surrogates appear at risk for suffering from clinically significant anxiety
symptoms following their service (Pochard et al., 2001). In a decision-making situation,
significant anxiety surrounding the potential ramifications or consequences can impede
surrogates’ abilities to adequately weigh risks, benefits, and the patient’s own values (Ganzini et
al., 1994), thereby undermining the extent to which they can accurately predict patient
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preferences (Rid & Wendler, 2010). Furthermore, service as surrogate requires confronting
distressing issues of mortality and end-of-life, which can stimulate feelings of depression and
sadness (Pochard et al., 2001). Among surrogates, depressive symptoms are associated with a
tendency to overestimate risks and underestimate benefits associated with treatment choices
(Ganzini et al., 1994). Therefore, surrogates who are experiencing negative emotions,
particularly anxiety or depressive symptoms, may make biased decisions that are less likely to
align with patients’ treatment preferences, as proposed by Pochard et al. (2001).
Willingness to Assume Responsibility for Decisions. Despite the tendency for patients
to report a relatively strong desire for information about treatment options, the extent to which
patients take primary responsibility for decisions about personal medical treatment can vary
considerably (Charles et al., 1997; Say, Murtagh, & Thompson, 2006). Patients who prefer more
“active” roles in treatment decision making tend to be those who also place greater value on their
health (Bishop & Yardley, 2004); however, being an “active” participant, such as by assuming
personal responsibility for a medical decision or engaging in shared decision making, is notably
distinct from simply being informed about one’s health and treatment options. In fact, evidence
suggests that even patients who express a strong desire for personally relevant medical
information may not necessarily desire active participation in decisions regarding their treatment,
instead preferring to defer these decisions to their providers (Vick & Scott, 1998).
When making a decision on behalf of oneself or for another person, decision-making
behaviors, including one’s desire to assume personal responsibility for a decision, often depend
on the extent to which this decision could impact others (e.g., Lu, Xie, & Xu, 2013; Stone &
Allgaier, 2008). For instance, findings from the behavioral economics literature indicate that
individuals are generally more loss-averse and more likely to select a less-risky alternative when
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making decisions on behalf of other people (Polman, 2012). In light of such self-other decisionmaking investigations, researchers (e.g., Tilden et al., 1999) have proposed that one’s willingness
to take responsibility for a decision may vary based on the extent to which the decision involves
another person. Investigations with healthcare providers have examined the degree to which
providers, particularly those who are still in training phases of their careers or who work as
members of interdisciplinary teams, are willing to take full responsibility for hypothetical
decisions regarding medication and treatment recommendations (e.g., Cope, Tully, & Hall, 2019;
Maddox et al., 2016). Factors such as self-efficacy (Cope et al., 2019), perceived role and level
of authority (Maddox et al., 2016), and perceived risk associated with the decision (Maddox et
al., 2016) appear associated with providers’ willingness to assume responsibility.
When making treatment decisions on behalf of patients, surrogates often perceive a great
deal of personal responsibility associated with their role (Tilden et al., 1999). Surrogates may be
uncomfortable with this sense of obligation, particularly when making medical decisions that
they perceive as requiring technical medical knowledge. Johnson and colleagues (2011)
employed an example of a “technical” medical decision in their investigation of how surrogates’
desires to take responsibility for a decision varied across different types of decisions. They
found that surrogates preferred to retain more responsibility for decisions they viewed as more
“value-based,” such as the decision of whether to keep a patient on life support, than for those
they viewed as more technical, such as the choice of which antibiotic to use to treat an infection.
While it is important to consider how surrogates may respond differently to various types of
decisions, the practical implications of these findings are minimal given that surrogates in real
clinical settings are more likely to be consulted regarding “value-based” decisions (Tejwani et
al., 2013).
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Value-based end-of-life decision research (e.g., Mezey et al., 1996; Uhlmann et al., 1988)
indicates that surrogates tend to choose treatment options with fewer associated risks or potential
negative consequences. Importantly, they tend to make these decisions regardless of whether
these choices align with patient preferences, which results in poor agreement. In a review of this
literature, Shalowitz and colleagues (2006) interpreted these findings as reflecting surrogates’
desires to minimize their sense of personal responsibility regarding such high-stakes decisions, in
a sense “deferring” potential liability for a negative outcome. Examining surrogates’ willingness
to assume responsibility for their decisions has important implications for more broadly
understanding and improving surrogate decision making. For instance, surrogates who express
greater willingness to take responsibility for their decisions are more likely to be willing to
engage in positive decision-making behaviors that could foster patient-surrogate agreement, such
as collaborating with the patient’s physician (Spalding & Edelstein, 2020).
Understanding Costs and Benefits of Treatment Options. Improving patient
understanding of treatment options, including details of potential risks, side effects, and
outcomes, is central to the prevailing model of shared decision making currently advocated by
the United States healthcare system (Kon et al., 2016). Prior research indicates that surrogates
who feel more well-informed regarding treatment options and the patient’s condition report
greater confidence in their decision making (Vig et al., 2007), which may promote the extent to
which they are able to attend to patient preferences.
Empathy. Davis’ multidimensional model of empathy is most commonly used in the
literature pertaining to self-other decision making and includes components of perspective taking
and empathic concern, or the ability to feel concern for others (cf. Davis, 1980). Both perspective
taking and empathic concern have been raised as central theoretical components of surrogate
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decision making under the substituted judgment standard (e.g., Tunney & Zeigler, 2015a). In an
examination of which components of Davis’ model of empathy were most strongly related to
decision making on behalf of others, Tunney and Zeigler (2015b) found that empathic concern
particularly predicted individual abilities to make judgments that more closely aligned with the
views of another person, rather than with their own preferences. Further evidence indicates
relations between individual differences in empathy and accuracy when making decisions on
behalf of others; for instance, Faro and Rottenstreich (2006) found support for an “empathy gap”
(Loewenstein, 2005) such that individuals with greater self-reported empathy were able to more
accurately predict others’ preferences in risky choice vignettes. Empathy may also affect
accuracy in the specific self-other decision-making situation of surrogate decision-making.
Qualitative explorations of the surrogate decision-making process support the role of empathy in
these contexts, as surrogates frequently identify empathy for the patient as influencing their
decision-making process (Meeker, 2004).
Religiosity and religious preference. Religiosity, or the extent to which one engages in
private and public religious practices, has yet to be formally examined in relation to surrogate
decision-making accuracy. Prior investigations (Coppolino & Ackerson, 2001) have found
religious affiliation to be unrelated to accuracy. That is, accuracy does not seem to vary across
members of specific religious groups. However, one’s particular commitment to religion and
beliefs surrounding the afterlife undoubtedly have bearing on one’s conceptualizations of end-oflife and preferences for care, as documented by research among patients and family surrogates
(Steinhauser et al., 2000). Therefore, by extension, religiosity could shape accuracy. No research
to date has examined relations between religious preferences and accuracy.
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Gender. Investigations of medical surrogate decision-making accuracy between marital
partners evidences gender differences, as wives tend to be more accurate than their husbands in
hypothetical surrogate decision-making tasks (Zettel-Watson et al., 2005).
Education. Education level is associated with health literacy and health outcomes more
broadly, such that health literacy mediates the association between low education and poorer
health (Van der Heide et al., 2013).
Ethnicity. In the United States, ethnic disparities in health outcomes and access to
healthcare resources are well-documented. Individuals of minority backgrounds generally report
poorer health, reduced health care utilization, and more frequent encounters with providerpatient discrimination (Lee, Ayers, & Kronenfeld, 2009), all of which are variables that can have
considerable bearing on end-of-life decision making.
Age. Finally, given research suggesting that preferences and beliefs surrounding lifesustaining treatment may vary across age groups (Phillips et al., 1996), age may also be related
to surrogates’ accuracy.
Surrogate Interpersonal Variables
Reluctance to Burden Others. Perceived burdensomeness, or the extent to which one
feels like a burden on other people, is a construct that has been heavily investigated in relation to
suicidality (Joiner et al., 2002; Van Orden et al., 2006) and depressive symptoms (Jahn et al.,
2011). However, concerns for excessively burdening significant others and potential caregivers
can occur under a variety of conditions. Such concerns appear prevalent among patients with
chronic pain (Kanzler et al., 2012), cancer (Simmons, 2007) and other critical illnesses (Zweibel
& Cassel, 1989), healthy adults (Tomlinson et al., 1990), and older adults (Cahill et al., 2009;
Kogan & Edelstein, 2004). Across the lifespan, fears of burdening loved ones appear most
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salient among younger adults and older adults, with relatively less concern of burdensomeness
reported at mid-life (Bausewein et al., 2013). These concerns can have an impact on individuals’
healthcare behaviors, such as when interacting with providers or participating in medical
decision making. For instance, cancer patients report that a main barrier that inhibits the
frequency with which they ask questions of their providers is their reluctance to burden the
physician (Maguire et al., 1996).
Winter and Parks (2012) investigated how reluctance to burden others (RBO) may
manifest in patient-surrogate relationships by asking pairs the extent to which they felt that RBO
affected their medical decisions, in general. When reporting on this variable, surrogates were
instructed to use the substituted judgment standard and provide an estimate of how much they
thought the patient considered RBO as relevant to their medical decisions. Findings indicated
that pairs with greater differences in RBO (e.g., pairs in which the patient rated that they were
much more concerned with burdening others than the surrogate had estimated, or vice versa)
were more likely to be those in which surrogates inaccurately predicted patient treatment
preferences. Therefore, surrogates’ inaccurate estimates of the patient’s RBO may predict their
accuracy when reporting the patient’s wishes.
Perceived Similarity between Self and Patient. In interpersonal relationships,
perceiving similarities between oneself and another person is beneficial for fostering feelings of
kinship and intimacy (Murray, 1999). This occurs when one perceives another person as
ascribing to one’s own beliefs, regardless of whether any explicit evidence has been given to
support this belief. For instance, research among pairs of well-acquainted adults shows a
particular tendency for individuals to project their own moral values onto others and view other
people as ascribing to their views (Cohen et al., 2013). Decisions about end-of-life treatment in
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particular may tap moral considerations associated with personal values surrounding death and
quality of life (Pellegrino, 2000). In proxy decision-making contexts in which one individual (the
“proxy”) is making choices on behalf of another person (the “patient”), proxies who assume that
patients share their personal values may be more accurate when predicting patients’ preferences,
if the proxy and patient hold similar beliefs (e.g., Cronbach, 1955). This follows under the valuebased conceptualization of medical treatment preferences as informed in part by one’s personal
beliefs (e.g., prioritizing quality of life over quantity; Winter, 2013).
However, if the values, and associated treatment preferences of the patient are in fact
dissimilar to those of the proxy, this assumption can undermine the proxy’s accuracy when
predicting patient preferences. This is particularly problematic in light of evidence indicating that
perceived similarity is quite high among pairs of close relatives who would likely serve as each
other’s surrogates, particularly among spouses (McDade-Montez, Watson, & Beer, 2013). In a
surrogate decision-making situation, surrogates may struggle to disconnect their own values from
those of the patient (Fagerlin et al., 2002), despite being instructed to use the substituted
judgment standard and make decisions that best reflect patients’ beliefs. This bias towards one’s
own personal values can reduce surrogates’ accuracy when attempting to predict medical
treatment preferences, as these preferences are often substantially informed by personal values
(e.g., Pruchno et al., 2005; Vig et al., 2007).
Perceived Emotional Support. Providing emotional support involves communicating
support, sympathy, and compassion for another person (Cohen & Wills, 1985). Emotionally
supportive messages can comfort individuals undergoing stress because such messaging conveys
another’s care and concern, regardless of the outcome of a situation (Weber & Patterson, 1991).
Research in intensive care settings, where patients and their family members often face stressful

15
medical decisions, indicate that emotional factors play an essential role in facilitating decision
making, particularly for surrogates (e.g., Nelson et al., 2006). Specifically, intervention
implementation studies with family members and surrogates reveal that interventions with an
emotional support component, in which a provider explicitly provides comfort or acknowledges
the surrogate’s present emotional difficulties, improve surrogates’ confidence in their own ability
to articulate patients’ values and communicate effectively with providers (e.g., White et al.,
2012; Gay et al., 2009). Furthermore, studies of provider behaviors during treatment decisionmaking interactions with surrogates indicate that providers’ activities that seek to provide
emotional support, such as expressing empathy (Selph et al., 2008) and maintaining consistent
communication (Pochard et al., 2001) are associated with patients’ improved satisfaction and
comfort with the decision-making experience. Although emotional support has not yet been
examined in relation to surrogate decision-making accuracy, an emotionally supportive
environment may enhance surrogates’ abilities to consider the decision-making situation and
render a decision that matches patients’ preferences. Specifically, the extent to which surrogates
perceive that they receive emotional support from their patient partner will be evaluated.
Trust in the Medical Profession. Over recent decades, shared decision making has
gained traction within the United States healthcare system as a prevailing model of clinical
practice (Elwyn et al., 2012; Kaplan, 2004). With this increased attention to promoting a
balanced involvement between patient and provider, factors influencing the patient-provider
relationship have come into focus. One such factor is patients’ degree of trust in the medical
profession. Generalized trust in the medical profession has been conceptualized as having five
central components: fidelity, competence, honesty, confidentiality, and global trust (a
combination of elements from each of the other four components that describes the “soul” of
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trust; Hall et al., 2002). Greater trust in the profession is also associated with better self-reported
health and higher satisfaction with care and the medical decision-making process among patients
(Armstrong et al., 2006). Moreover, trust in the profession appears strongly related to views
regarding personal involvement in medical decision making than trust in specific providers (Hall
et al., 2002; Trachtenberg et al., 2005), with greater trust in the profession associated with more
accepting views towards shared decision making (Arora & McHorney, 2000; Blanchard et al.,
1988; Trachtenberg et al., 2005).
Low levels of trust in the medical profession may make decision making more difficult
for patients and has been purported to reduce the quality of their medical decisions (Torke et al.,
2014). The extent to which surrogates’ levels of trust affect the decisions they make for patients
or their decision-making behaviors has yet to be explored. Feelings of trust towards the
profession likely varies among surrogates, as these feelings are informed by individuals’ unique
prior experiences in the context of the healthcare system, whether through their own healthcare
interactions or when serving as a surrogate. Surrogates with a high degree of trust in the medical
profession may feel more supported in their decision making and be better equipped to provide
more accurate reflections of patient preferences.
Degree of Communication with Partner about End-of-Life Treatment Preferences.
Similar to how a better understanding of treatment options promotes surrogates’ confidence in
their decisions, surrogates who have engaged in more communication with patients about their
preferred care at end-of-life report that this facilitates their ability to serve in the role (Vig et al.,
2007). One could expect that surrogates who report that they have discussed preferred treatments
more extensively with patients would be more accurate predictors of their preferences.
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Consideration of COVID-19. Lastly, given the unique circumstances of a global
pandemic under which data collection occurred, the potential role of the COVID-19 pandemic
was considered. Recent research has found associations between the onset of the current
COVID-19 pandemic and worsened mental health outcomes, in terms of increased anxiety and
depression symptoms, with these symptoms heightening as the pandemic continued (e.g., Ahmed
et al., 2020; Tang et al., 2020). As previously described, anxiety and depression have been found
to significantly alter one’s performance in medical decision-making contexts (Hartley & Phelps,
2012; Paulus & Angela, 2012). Therefore, the extent to which surrogates reported feelings of
anxiety or concern regarding the pandemic was included as a predictor variable because it could
potentially influence medical decision making.
Statement of the Problem
Despite consensus among the research community that surrogate decision-making
accuracy is a pertinent topic, little to no research to date has investigated what variables predict
accuracy. Researchers have suggested that future endeavors need to adopt a more nuanced
approach to surrogate decision making, assessing individual variables that may be involved in
the process (Berger, 2010; Spalding, 2020; Tunney & Zeigler, 2015). Efforts to manipulate these
variables could improve surrogates’ accuracy, if patient-surrogate agreement on decisions is the
main objective of surrogate decision making, as it is currently under the favored substituted
judgment standard.
The current study sought to replicate the study by Hare et al. (1992) in which they
investigated surrogate medical decision-making accuracy. These authors administered five
hypothetical treatment decision vignettes to patient-surrogate pairs and investigated the extent to
which agreement between pairs occurred. Findings indicated that agreement between patients
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and their surrogates occurred, on average, 70% of the time. In other words, surrogates predicted
patient preferences with an accuracy level worse than chance, as kappa values ranged from .14 .42 across the decision vignettes. The current study also extended this work by investigating the
extent to which specific variables can predict accuracy. Variables were grouped into two main
categories: intrapersonal characteristics of surrogates themselves (including demographic
features of age, race/ethnicity, education level, and type of relationship between patient and
surrogate), and interpersonal variables operating between surrogates and other individuals who
may be involved in the decision-making process. Furthermore, in light of evidence that
surrogates’ decision-making preferences and behaviors can vary based on the type of decision
being made (Johnson et al., 2011; Spalding & Edelstein, 2020), this study also investigated
whether the variables that predict accuracy differ across the decision vignettes. Given the relative
dearth of research in this area, the current study was broad and exploratory in scope. Ultimately,
this study aimed to more explicitly identify variables for investigation and manipulation in future
research designs and interventions pertaining to surrogate decision-making accuracy.
Research Questions
1) To what extent are the selected intrapersonal and interpersonal variables related to
accuracy?
a. Do the variables predict surrogates’ accuracy when attempting to execute the
substituted judgment standard on hypothetical surrogate end-of-life treatment
decisions?
i. Intrapersonal variables: surrogates’ age, education level, self-rated
physical health, COVID-19-related anxiety, religiosity, trait-level
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anxiety, depression, empathy, understanding of treatment options,
willingness to assume full responsibility for decisions
ii. Interpersonal variables: surrogates’ trust in the medical profession,
surrogates’ perceived emotional support from partner, surrogates’
perception of the extent to which the patient is reluctant to burden
others, extent to which surrogate has communicated with partner about
end-of-life treatment preferences, difference between surrogates’ and
patients’ perceived similarity on end-of-life values, surrogates’
perceived similarity to patients on end-of-life values
2) Do the variables that predict accuracy differ based on the type of decision being
made?
3) What patient-reported variables predict accuracy?
Method
Design
Since assessing surrogates’ accuracy relative to real end-of-life treatment decisionmaking situations poses great methodological difficulties, most studies in this literature have
employed procedures involving hypothetical decision-making vignettes. In these studies, patients
and their designated surrogates (or individuals who would most likely serve in this role) are
asked to select the treatment decision they would make for themselves or on behalf of the patient
in various vignettes associated with terminal health conditions or end-of-life. For instance, in one
representative study, Hare, Pratt, and Nelson (1992) administered five case vignettes to pairs of
community outpatients and their designated surrogates regarding preferences for life-sustaining
interventions (mechanical ventilation, cardiopulmonary resuscitation, chemotherapy, feeding
tube implantation, emergency amputation; see Appendix B).
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The current study followed the dyadic, survey-based methodology of Hare et al. (1992).
Similar online survey methodologies have been successfully used in recent dyadic studies,
including those with married couples (e.g., Helsper & Whitty, 2010), parents and children (e.g.,
Oh et al., 2016), grandparents and grandchildren (e.g., Spalding & Carpenter, 2018), cancer
patients and care partners (e.g., Hamilton et al., 2016), and older adults and their caregivers (e.g.,
Nahm et al., 2012). To ameliorate a procedural weakness of the original study, an adjustment
was made to the manner by which surveys were administered to patient-surrogate pairs. Hare et
al. (1992) disseminated surveys to participants via postal mail and offered a substantial response
window during which surveys could be returned. Despite being instructed not to discuss the
study with others at the time of recruitment, patients and surrogates may have nonetheless
discussed patients’ end-of-life care preferences prior to returning the surveys, potentially
inflating estimates of surrogates’ accuracy. In an attempt to discourage patient-surrogate
discussion during study participation, participants read and signed an electronic confidentiality
statement twice: once upon beginning the online survey, and again at completion.
Recruitment & Participation Procedures
All study procedures occurred through an online survey hosted through Qualtrics.
“Patient” participants with a healthcare surrogate, or who could identify an individual most likely
to serve in this role, were initially recruited through Amazon Mechanical Turk and the West
Virginia University (WVU) alumni and faculty listserv (Mountaineer ENews). Since issues
related to medical treatment decisions and end-of-life are likely most salient for middle-aged and
older adults, a minimum age criterion of 45 years old was used for patients. At the time of
participation, patients were provided with a link to an online survey to share with their surrogate
partner for them to complete. Once connected to the survey link, both patients and surrogates
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indicated their consent to participate by reading a consent form, provided as Page 1 of the online
survey, and proceeded to the next page of the survey. Surrogates were required to be over age 18,
capable of reading English, and to have access to an email account.
Data collection occurred in two stages. In the first stage, approximately May 1, 2020 –
July 3, 2020, pairs of surrogates and patients were recruited through MTurk. During the first
stage, both patients and surrogates were compensated $1 for their participation over MTurk or
through an Amazon gift card sent to an email account. However, after the participation
advertisement had been posted on MTurk for about two months, the pool for eligible and
interested participants appeared to have been exhausted. At this point, the WVU alumni and
faculty listserv (ENews) was used as an alternate recruitment source in the second stage of the
study, approximately July 15, 2020 – August 1, 2020. To further incentivize recruitment,
compensation for participation was also increased to a $2 Amazon gift card, dispersed to one’s
email account, for both patient and surrogate at this time. In an effort to discourage missing data,
or cases in which only one member of a dyad completed the survey, pairs in which both patient
and surrogate respond were entered into a drawing for a $100 Amazon gift card. Participants
were informed of compensation and the potential to be selected through the raffle drawing at the
time of consent.
First, all participants completed a demographic questionnaire (see Appendix A). As part
of this questionnaire, participants also provided the email address of the individual who would be
participating as their “partner” (either as the corresponding patient or surrogate) in the study. At
this time, participants read and signed an electronic confidentiality statement indicating their
pledge to not discuss the contents of this survey with their partner. The confidentiality statement
included an explanation of why such non-disclosure was necessary.
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Following the demographic questionnaire, participants completed the online survey. Two
versions of the online survey were created: a surrogate version and a patient version. The
versions differed based on the language used in the hypothetical medical decision vignettes. The
first portion of the survey consisted of hypothetical medical decision vignettes, including those
designed by Hare et al. (1992; see Appendix B). Surrogates were instructed to complete the
decisions using the substituted judgment standard on behalf of the patient. Patients were
instructed to complete the decisions to indicate their own preferences.
Next, all participants completed self-report measures corresponding to each of the
predictor variables (see Appendices C-J). To control for order effects, the order in which
participants completed these measures was randomized. In the final stage of the survey,
participants again read and signed an electronic confidentiality statement indicating that they did
not discuss contents of the survey with their partner.
Validity Check Items. Several validity check measures were incorporated to promote the
collection of high-quality data. First, to check for valid age reporting, participants were asked to
report their age and birth year at the beginning of the survey and at its conclusion. Responses
with discrepancies of greater than 1 year were discarded. Second, each of the self-report
measures included one validity check item (e.g., “Please select “very much so” for this item.”) to
check for participants’ attention to the study materials. Responses reflecting more than one
incorrect attention check response were not included in analyses. Third, for each version of the
survey, responses that omitted more than 25% of the survey items, or those that omitted an entire
measure, were discarded.
Participants
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One-hundred-and-sixty-one pairs, or 322 total participants, were recruited. Patients were
recruited first through advertisements posted on MTurk and ENews. At the time of their
participation, patients were asked to identify an individual from their lives who would likely
serve as their surrogate and who could participate as their “partner” in the study. Then, they
referred this person to the study using a provided survey link. One-hundred-and-one pairs were
recruited through ENews, whereas 60 pairs responded through MTurk.
Of the 161 total pairs recruited, seven pairs were excluded from subsequent analyses:
three pairs due to the surrogate’s omission of a substantial portion of the survey, three due to the
patient’s omission of a substantial portion of the survey, and one due to the surrogate responding
incorrectly to more than one attention check item. Therefore, a final sample of 154 patientsurrogate pairs remained.
Surrogate Characteristics.
Surrogate participants ranged in age from 22 to 88 years old (M = 47.38 years; SD =
9.98) and reported an average of 15 years of education (SD = 4.32). Surrogates recruited via
ENews were slightly older than those recruited via MTurk, with a mean age of 48.65 and 45.38,
respectively. Over three-quarters of surrogates identified as Christian (57.8%) or Roman
Catholic (18.8%). All surrogates resided in the United States, with 20.8% reporting residence in
the Midwest, 29.9% in the Northeast, 9.1% in the Northwest, 26.9% in the Southeast, and 11.9%
in the Southwest. The majority of surrogates identified as female, married, and White/Caucasian
(see Table 1). In terms of reported relation to their patient partner, most (83.8%) of the
surrogates were spouses or romantic partners, 7.1% were parents, 3.9% were siblings, 3.9% were
close friends, and .6% were adult children or another family member. Surrogates reported
relative familiarity with the role of serving as a surrogate, with 77.9% indicating that they had
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served as a surrogate in a formal capacity (per the request of a physician) and 76.6% reporting
informal service. Only 2 surrogates indicated that they did not have health insurance and most
reported generally good self-rated physical health on a scale of “1 = poor” to “5 = excellent,” M
= 3.63, SD = .840.
Patient Characteristics.
Patient participants ranged in age from 45 to 71 years old (M = 51.24, SD = 5.52) and
reported 15.5 years of education (SD = 4.66), on average. No significant demographic
differences were observed between those recruited via MTurk versus ENews. One patient
indicated that they did not have health insurance. Similar to the surrogate sample, over threequarters of patients identified as Christian (58.4%) or Roman Catholic (14%). The majority of
patients identified as male, married, and White/Caucasian (see Table 2). All patients reported
residing in the United States, with 21.6% identifying residence in the Midwest, 30.1% in the
Northeast, 10.7% in the Northwest, 22.9% in the Southeast, and 15.0% in the Southwest. Patients
rated their physical health as “good,” on average (M = 3.55, SD = .85).
Materials
Criterion Variable Measure
Choice of End-of-Life Medical Treatment. As a replication of Hare et al. (1992), the
current study employed the same five medical treatment decision vignettes used in this study, in
addition to two decision vignettes commonly considered in advance directive end-of-life
treatment preference documentation (White & Arnold, 2011; see Appendix B). The vignettes
asked respondents to choose whether to administer a treatment in situations concerning the
following: ventilation, resuscitation, tube feeding, chemotherapy, amputation, bypass surgery,
and dialysis treatment for chronic kidney disease. Surrogates were instructed to make decisions
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using the substituted judgment standard and make the decision they thought the patient would
make. Patients made decisions on the vignettes as self-report, indicating the treatment that they
would want to be provided. Wording in the vignettes was identical for both patient and surrogate
versions, except for minor changes to indicate that the respondent was the patient. In response to
each vignette, respondents selected either to accept (scored as “1”) or decline (scored as “0”) the
treatment that is explained and offered in the vignette. Scores were summed across the vignettes
to create a total treatment selection score, with higher scores indicating a stronger tendency to
accept presented treatment interventions. This “intervention preference” score was used in
subsequent analyses. To operationalize surrogates’ accuracy, patient-surrogate agreement scores
were calculated for each pair using a similar method to that used by Hare et al. (1992). Vignettes
on which the pair agreed were scored as 1 and summed. Therefore, agreement scores for each
pair ranged from 0 to 7, with higher scores denoting higher agreement, or greater accuracy by the
surrogate.
Predictor Variable Measures
In the primary regression analysis evaluating the prediction of surrogates’ accuracy when
making treatment decisions, surrogates’ self-reports were used as predictor variables. Note,
however, that both patients and surrogates completed these measures.
In relation to the treatment decisions, participants were also asked to rate, on a 5-point
Likert-type scale, the extent to which they felt they understood the costs and benefits associated
with the treatment that was being offered for each decision. Scores were summed across the
seven vignettes to obtain a total “treatment understanding” score ranging from 7 to 35. Higher
scores reflected greater self-assessed understanding. Surrogates also responded to a single item
indicating the extent to which they had talked with their partner about end-of-life care
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preferences, using a 4-point scale, where “1= not at all,” “2=a little,” “3=moderately,” and
“4=very much.”
COVID-19. As part of the demographics questionnaire to assess respondents’ current
experience of the pandemic, each participant rated the following statement on a 10-point scale,
with ratings ranging from “1= not at all” to “10 = very much so,” in response to the following
question: “How worried are you about the COVID-19 pandemic?”
Trust in the Medical Profession. The extent to which participants trusted the medical
profession in general was assessed by the 11-item scale developed by Hall and colleagues
(TIMPS; Hall et al., 2002). Respondents used a five-point Likert scale ranging from 1 (strongly
disagree) to 5 (strongly agree) to rate the extent to which they trust the medical profession in
general (e.g., “Doctors are extremely thorough and careful.”). The measure has been widely used
in investigations of patients’ trust in the medical profession (e.g., Klest & Philippon, 2016; Thom
et al., 2004) and demonstrates good psychometric properties, with high internal consistency
reliability ( = .89; Hall et al., 2002) among nationally representative community-dwelling
samples. Convergent validity evidence was provided for this measure through demonstrated
positive relations with measures of satisfaction with care, trust in one’s physician, and
willingness to follow physician recommendations (Hall et al., 2002).
Perceived Emotional Support. The Communication Based Emotion Support Scale
(CBESS; Weber & Patterson, 1996) assessed the degree to which participants perceive that they
receive emotionally supportive messages from their partner in this study. This 13-item,
unidimensional self-report measure uses a five-point Likert-type scale ranging from 1 (almost
never true) to 5 (almost always true). Although this measure was originally developed for use
with romantic partners, it has been successfully modified with slight wording changes for use
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when assessing views of emotional support given by friends and significant others (e.g.,
Rittenour & Martin, 2008). Both the original version of the scale and modified versions
demonstrate strong psychometric properties, with good internal consistency reliability reported
for the original scale ( = .83-.90, Avtgis, 2003; Weber, Johnson, & Corrigan, 2004) and the
modified version ( = .93; Rittenour & Martin, 2008). Convergent validity evidence for this
measure exists through demonstrated positive associations between scores on this measure and
self-reported relationship quality (Weber & Patterson, 1996), multidimensional perceived social
support, and engagement in social support behaviors with significant others (Rittenour & Martin,
2008). Since the current study was interested in measuring respondents’ feelings of emotional
support regarding their partner in this study, slight wording modifications were made to the
original measure (e.g., substituting “your partner in this study” for “romantic partner”).
Perceived Similarity between Self and Patient. To assess surrogates’ perceived
similarity to patients regarding values specifically related to end-of-life treatment, the Quality of
Life Values Inventory (QLVI; Cohen-Mansfield, Droge, & Billig, 1992) was used. Respondents
used a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree) to indicate
their level of agreement with five statements reflecting the relative importance they place on
quality of life, prolonging life, and placing burden on others (e.g., “I’d rather not live than be a
burden on others.”). The QLVI demonstrates adequate internal consistency reliability among
community-dwelling samples ( = .61 - .67; Cohen-Mansfield et al., 1992; Cicirelli, 1997).
Convergent validity evidence for this values measure exists in its demonstrated relations to endof-life treatment preferences, the number of additional years respondents desired to live, and
measures of multidimensional locus of control (Cicirelli, 1997; Cohen-Mansfield et al., 1992).

28
As an additional measure of values related to quality of life at end-of-life, the 13-item
Life Values measure designed by Schonwetter and colleagues (LVI; 1996) was used. Created as
a modification of Doukas & McCullough’s (1991) Values History, the measure asks respondents
to use a five-point Likert-type scale ranging from 1 (“not at all true for me”) to 5 (“very true for
me”) in response to a series of statements regarding values related to end-of-life.
To assess perceived similarity, participants rated each of the 18 items from both of these
measures using a five-point Likert-type scale ranging from 1 (exactly the opposite of me) to 5
(exactly the same as me) to reflect the extent to which they thought their partner’s values
regarding the item were similar to their own. Ratings on the items were summed to produce a
total perceived similarity score ranging from 18 to 90.
Empathy. The extent to which participants possessed empathy, or concern for others,
was measured by Davis’ (1980) 28-item Interpersonal Reactivity Index (IRI), scored on a 5-point
Likert-type scale with possible scores ranging from 28 to 140. The IRI measures empathy across
four subscales including perspective taking, fantasy, empathic concern, and personal distress.
Satisfactory internal consistency reliability has been demonstrated for this measure ( = .71 .77; Davis, 1980).
Willingness to Assume Full Responsibility for Medical Decisions. The extent to which
participants were willing to take full personal responsibility for medical decisions was assessed
using the behavioral involvement subscale of the Health Opinion Survey (HOS; Krantz, Baum,
& Wideman, 1980). This subscale consists of nine items focusing on the respondent’s desire to
participate in self-management of their medical treatment and care (e.g., “It’s almost always
better to seek professional help than to try to treat yourself.”). For each item, respondents
indicated either 0 (disagree) or 1 (agree); therefore, scores on this measure ranged from 0 to 9,
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with higher scores indicating favorable attitudes towards self-directed decisions about medical
treatment. Possible scores therefore ranged from 0 to 81. According to a review of measures of
patient preferences for shared decision making (Chewning et al., 2012), the behavioral
involvement scale demonstrates good internal consistency reliability (KR-20 = .74 - .75). Good
test-retest reliability for the subscale has also been reported ( = .71; Krantz et al., 1980).
Convergent validity evidence for the subscale has been demonstrated through positive relations
between scores on the subscale and behavioral measures of engagement in self-management of
health care (e.g., those who score higher on the subscale tend to be those who attempt to treat
themselves first before presenting for treatment in a medical clinic; Krantz et al., 1980).
Anxiety. The State-Trait Anxiety Scale, Trait Subscale (STAI-T; Spielberger, 1983)
assessed trait-level anxiety. The STAI-T is a 20-item instrument that measures the respondent’s
tendency to experience anxiety and perceive situations as threatening. Respondents indicated the
degree to which each statement is true of themselves, in general, on a Likert-type scale ranging
from 1 (not at all) to 4 (very much so). Possible scores ranged from 20 to 80, with higher scores
indicating greater levels of trait-level anxiety. The measure has high test-retest reliability,
ranging from .73 – 86. Strong concurrent validity evidence with other measures of anxiety has
been reported, ranging from .73 –.85 (Spielberger, 1983).
Depression. The Center for Epidemiological Studies Depression Scale-Revised (CESDR; Eaton et al., 2004) assessed depressive symptoms. The measure is an updated version of the
CES-D (Radloff, 1977) and consists of 20 items reflecting depressive symptoms consistent with
DSM-V criteria for depression. Respondents indicated the frequency with which they have
experienced each symptom over the past 2 weeks using a scale ranging from 1 (not at all or less
than 1 day) to 5 (nearly every day for the past 2 weeks). The measure is scored on a scale of 0 –
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3, with responses indicating a frequency of 4 (5-7 days) or 5 (nearly every day) both receiving a
score of 3. Total scores on the measure therefore ranged from 0 to 60, with higher scores
indicating greater depressive symptoms. The measure demonstrates good psychometric
properties, with high internal consistency reliability among community-dwelling samples ( = .93, Van dam & Earleywine, 2011) and good convergent validity with measures of theoretically
associated constructs, such as negative affect (Van dam & Earleywine, 2011).
Reluctance to Burden Others. This exploratory variable was assessed using the measure
developed by Winter and Parks (RBO; Winter & Parks, 2012). Three items reflected three
components of perceived burdensomeness through the following questions: “To what extent do
you feel it is important to avoid burdening your family and friends emotionally as a result of
your medical treatment decisions?”, “To what extent do you feel it is important to avoid
burdening your family and friends financially as a result of your medical treatment decisions?”,
“To what extent do you feel it is important to avoid being dependent on others as a result of your
medical treatment decisions?”. Surrogates were instructed to respond to these items using the
substituted judgment standard. Therefore, they provided the response they thought the patient
would choose on a Likert-type scale ranging from 1 (not at all important) to 5 (very important).
Ratings on the items were summed to produce a total RBO score ranging from 5 to 15. Patients
completed this measure as a self-report. Differences between patients’ self-reported reluctance to
burden others and surrogates’ proxy reports were also computed to examine relative to
surrogates’ accuracy, in an attempt to replicate findings from Winter and Parks (2012).
Religiosity. This construct was assessed by the Duke University Religion Index
(DUREL). The DUREL measures religiosity through five self-report items (Koenig & Bussing,
2010). The first three items ask respondents to indicate the frequency with which they participate
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in certain religious activities, using a 6-point scale ranging from “1 = never” to “6 = more than
once a day.” The final items measure intrinsic religiosity, such as experiencing the presence of a
higher power, on a 6-point scale ranging from “1 = definitely not true of me” to “6 = definitely
true of me.” Total scores therefore ranged from 6 to 30, with higher scores indicative of greater
religiosity. The measure demonstrates adequate internal consistency reliability ( = .78-.91) and
convergent validity evidence through strong correlations with other religiosity measures (r = .71.86; Koenig & Bussing, 2010).
Results
Handling of Missing Data
Missing values analyses verified that patterns of missingness occurring in the data were
consistent with missingness patterns completely at random or at random. An expectation
maximization procedure was then used to account for problematic missingness in measures
(greater than 5% of items; Field, 2013). Values imputed via expectation maximization were used
for the CESD-R, the QLVI and LVI, the IRI, the TIMPS, and the STAI.
Of note, data collection was attempted for two additional variables: social norms
pertaining to treatment options, and the extent to which participants felt confident that the
decisions they made on treatment vignettes were consistent with what the patient would have
wanted. However, unforeseen patterns of missingness arose for these variables, and greater than
30% of surrogates failed to complete these items. When the regression analysis was conducted
across all vignettes with the smaller sample of participants who completed these items (108
surrogates), the predictive model was still not significant. Therefore, these variables were
determined to not contribute any additional information and were excluded from further
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analyses. Correlations between these variables and major outcome variables (agreement scores
and intervention selection) are available in Appendix K.
Organization of Results
First, descriptive results pertaining to the intrapersonal and interpersonal variables are
presented. Means and standard deviations for these variables, as reported by surrogates, appear in
Table 5. Next, since two recruitment methods (WVU ENews and MTurk) were used, results of
analyses comparing samples from the two recruitment sources are provided. The section
concludes by presenting results pertaining to each of the main research questions.
Intrapersonal variables
Surrogates reported moderately high levels of empathy on the IRI. The IRI demonstrated
good internal consistency reliability ( = .77) for the current sample. As measured by the HOS,
surrogates demonstrated a tendency to view treatment decision-making autonomy as
appropriately placed in the hands of the physician, (skew = -.871). Adequate internal consistency
reliability was evident,  = .68.
In general, surrogates reported moderate levels of religiosity. Internal consistency
reliability on the DUREL was excellent,  = .91. Surrogates reported average trait levels of
anxiety on the STAI-T and internal consistency reliability was excellent,  = .88. However,
surrogates reported very high levels of anxiety specific to the COVID-19 pandemic (skew = 1.79) on a 9-point scale. Surrogates reported minimal depressive symptoms on the CESD-R.
Internal consistency reliability for the CESD-R was excellent,  = .98.
Surrogates reported very high levels of anxiety specific to COVID-19 (skew = -1.79).
Patients also reported elevated levels of worry regarding the virus, skew = -1.32. A square root
transformation was performed on skewed variables for use in subsequent analyses.
Interpersonal variables
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Surrogates reported moderate levels of trust in the medical profession on the TIMPS.
Internal consistency reliability for the TIMPS was good,  = .84. On the CBESS, surrogates
reported receiving generally sound emotional support from their partners. Internal consistency
reliability was excellent ( = .90) for the current sample.
When reporting on behalf of their partners on the RBO, surrogates estimated the
importance of avoiding being a burden on others as being moderate to strong. For the current
sample, internal consistency reliability for the RBO was good,  = .79. Surrogates reported
moderately high feelings of similarity towards their partners on values related to end-of-life on
the combined QLVI and LVI measure. Internal consistency reliability was excellent ( = .91) for
the current sample. For use in the regression analysis predicting agreement scores, patients also
completed the QLVI and the LVI. A difference score was calculated between patients’ and
surrogates’ perceptions of their similarity on these values-related items. Discrepancies between
surrogates’ and patients’ perceived similarities on values was as high as 49 points on the
combined scale, with an average difference of 17.05 (SD = 11.73).
Comparisons between recruitment sources
Independent-samples t-tests evaluated differences between the participant groups
recruited from MTurk and Mountaineer ENews on key study variables. Surrogates significantly
differed across recruitment methods on the following variables: willingness to assume
responsibility for medical decisions, trust in the medical profession, anxiety, COVID-19-related
worry, religiosity, and the extent to which they reported discussing end-of-life preferences with
their partners. Specifically, surrogates recruited from ENews reported higher levels of anxiety (t
(152) = -3.65, p < .05), COVID-19-related worry (t (152) = -2.34, p < .05), religiosity (t (149) = -
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1.52, p < .05), and greater willingness to take responsibility for medical decisions, t (147) = 3.09, p < .05.
Among patients, a similar pattern emerged such that those recruited from ENews reported
higher levels of COVID-19-related worry (t (151) = -3.35, p < .005) and anxiety (t (151) = -2.00,
p < .05). Differences in anxiety and COVID-19-related worry may be attributed to the fact that
MTurk participants were recruited at a slightly earlier point during the global pandemic, when
pandemic-related stressors and restrictions were relatively new.
Finally, surrogates from ENews indicated lower levels of trust in the medical profession
(t (147) = .831, p < .05) and reported that they had engaged in relatively more discussion about
end-of-life treatment with their partners, t (152) = -1.132, p < .05. Patients recruited through
ENews were more likely to approve treatment interventions than those recruited through MTurk,
t (151)= -2.64, p < .05. However, agreement scores did not significantly differ across recruitment
groups. For both patients and surrogates, no significant demographic differences were detected
across recruitment samples.
Treatment selection and accuracy
Across the decision vignettes, surrogates tended to approve administration of treatment,
with an average treatment intervention score of 5.63 on the 7-point intervention selection scale.
Notably, 42.9% of surrogates indicated that they would choose to provide treatment in all 7
vignettes. For patients, there was also a tendency to approve treatment options, with an average
score of 5.46, and 39.2% of patients desiring provision of treatment in all 7 vignettes. The kappa
statistic was calculated to measure agreement between patient-surrogate pairs. Kappa is a
measure of agreement that is favored in the surrogate decision-making accuracy literature to
date, since it provides a measure of agreement that is corrected for chance agreement, unlike
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percent agreement. Across the decision vignettes, agreement between patients and their
surrogates on treatment selections was worse than that which would be expected by chance
alone, kappa = .268, p < .000. Guidelines from Cicchetti and Sparrow (1981) classify this level
of agreement as “poor.” Of the 154 pairs, 46.1% agreed on all seven decision scenarios;
therefore, 53.9% of the sample featured a surrogate inaccurately predicting the patient’s
preferences on at least one treatment decision. When predicting preferences, surrogates could err
by “overtreating,” or providing interventions that the patient would not have selected, or by
“undertreating” and withholding a desired intervention. Of the 80 pairs in which the surrogate
inaccurately predicted preferences for at least one scenario, 49 (61.2%) featured the surrogate
undertreating, while 31 (38.8%) indicated overtreating.
When evaluating agreement for each decision vignette individually, agreement was
lowest for the decision regarding ventilation, in which 75.6% of pairs agreed on the decision, and
highest for the decision pertaining to coronary bypass surgery, 88.8% agreement; see Table 3.
Surrogates reported a relatively high degree of treatment understanding across the 7
vignettes and reported that they had discussed end-of-life treatment preferences with patients to a
moderate extent; see Table 5.
Research Question 1. To what extent are the selected intrapersonal and
interpersonal variables related to accuracy? Do the variables predict surrogates’ accuracy
when attempting to execute the substituted judgment standard on hypothetical surrogate
end-of-life treatment decisions?
First, bivariate correlation analyses revealed significant relations between accuracy and
several of the variables individually (see Table 4). In terms of intrapersonal variables, surrogates’
accuracy when predicting preferences was positively correlated with levels of empathy and
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religiosity, r (154) = .25, p < .005; r (151) = .24, p < .005, respectively. Therefore, surrogates
who reported higher levels of these constructs were more accurate. Surrogates’ levels of trust in
the medical profession were also positively correlated with accuracy, r (154) = .18, p < .05.
When considering their partners’ values, surrogates who reported greater perceived
similarity to their patients regarding end-of-life values and who perceived their partners as more
reluctant to burden others tended to be more accurate, r (154) = .26, p < .005 and r (152) = .18, p
< .05, respectively. Pairs who reported high discrepancies in perceived similarity on end-of-life
values (e.g., the patient reported low similarity while their surrogate reported high similarity, and
vice versa) were those in which surrogates were better predictors of treatment preferences, r
(154) = .22, p < .05.
According to a series of one-way ANOVAs, accuracy did not significantly differ across
various demographic variables, including the surrogate’s gender, marital status, ethnicity,
religious preference, or relationship to the patient. According to an independent-samples t-test,
surrogates who reported prior experience serving as a surrogate were more likely to accurately
predict patient preferences than those who denied such experience, t (151) = 4.59, p < .05.
Significant correlates were then included in a multiple linear regression analysis to
evaluate the prediction of surrogates’ accuracy. The criterion variable was accuracy,
operationalized as total agreement scores computed across the seven vignettes, ranging from 0 to
7. Specifically, the following predictor variables were used: surrogates’ ratings of trust,
religiosity, empathy, perceived similarity to patients on end-of-life values, perceived degree of
patients’ reluctance to burden others, and differences between patients and surrogates on end-oflife values. Collinearity diagnostics, variance inflation factors, and tolerance values were within
normal limits. Conditioning plots and Levene’s test supported assumptions of equality of

37
variances and normal distributions. The overall predictive model was significant, F(6) = 3.03, R2
= .12, p = .008. None of the variables appeared as unique predictors; see Table 7.
Follow-up analyses. In an exploratory linear regression analysis, all of the intrapersonal
and interpersonal variables of interest were used to predict surrogates’ intervention selections. In
other words, these variables were used to predict surrogates’ tendencies to approve treatment
administration in the decision vignettes. The variables significantly predicted treatment selection,
F (16) = 2.28, R2 = .24, p = .006. Of the predictor variables, the only unique predictor was
COVID-19-related anxiety, β = .28, p < .005.
Research Question 2. How does the prediction of accuracy differ based on the type
of decision being made? Separate logistic regression analyses were conducted for each of the
seven decision vignettes individually, using all of the intrapersonal and interpersonal variables of
interest as predictors. Variables were used to predict agreement scores (scored as 0 = agree, or 1
= disagree) for each decision individually. Three of the seven decision scenarios produced
significant predictive models.
For the decision regarding whether to administer ventilation, the logistic regression
model was statistically significant, X2 (16) = 31.24, p < .05. The model explained 30.1%
(Nagelkerke R2) of the variance in agreement and correctly classified 79.9% of cases. Greater
empathy and perceived similarity to patients on end-of-life values was associated with an
increased likelihood of agreement on this decision.
The logistic regression model was also statistically significant for the decision of whether
to provide dialysis treatment, X2 (16) = 29.95, p < .05. The model explained 35.2% (Nagelkerke
R2) of the variance in agreement and correctly classified 87.3% of cases. Of the predictive
variables, surrogates who reported less desire to take personal responsibility for medical
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decisions tended to provide more accurate predictions of their partners’ preferences with regards
to dialysis treatment.
Finally, for the decision regarding whether to provide cardiac bypass surgery, the logistic
regression model was statistically significant, X2 (16) = 29.00, p < .05. The model explained
38.6% (Nagelkerke R2) of the variance in agreement and correctly classified 90.3% of cases.
According to surrogates’ reports, engaging in greater discussion of end-of-life preferences with
their partners was associated with greater agreement on this decision. Greater empathy and
perceived similarity to patients on end-of-life values was associated with an increased likelihood
of agreement on this decision. In other words, the combination of empathy and perceived
similarity levels were predictive of surrogates’ accuracy when predicting preferences.
The logistic regression models pertaining to the interventions of CPR, a feeding tube,
chemotherapy, and amputation were not statistically significant.
Research Question 3. What patient-reported variables predict accuracy?
Since similar data were collected for both patient and surrogate participants, a multiple
linear regression analysis also evaluated the prediction of total agreement scores across all seven
vignettes using patient-reported intrapersonal and interpersonal variables as predictors. The
criterion variable was total agreement scores, ranging from 0 to 7, across the seven vignettes.
Collinearity diagnostics, variance inflation factors, and tolerance values were within normal
limits. Conditioning plots and Levene’s test supported assumptions of equality of variances and
normal distributions. The overall predictive model was not significant, F (16) = 1.84, R2 = .16, p
= .06.
Discussion
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The current study aimed to replicate and extend Hare and colleagues’ (1992)
investigation of surrogate medical decision-making accuracy by examining decision making
between patient-surrogate pairs on hypothetical treatment decision vignettes. In addition to
examining the relation between accuracy and specific variables, the study evaluated the extent to
which surrogates accurately predicted patients’ preferences. Variables were drawn from two
categories: intrapersonal variables pertaining to surrogates themselves, and interpersonal
variables related to surrogates’ relationships with their patient partners, perceptions of their
partners, and views of the medical profession in general.
The following were considered as intrapersonal variables in the primary analyses:
surrogates’ age, education level, self-rated physical health, COVID-19-related anxiety,
religiosity, trait-level anxiety, depression, empathy, understanding of costs and benefits related to
treatment options, willingness to assume full responsibility for decisions. Interpersonal variables
included: surrogates’ trust in the medical profession, surrogates’ perceived emotional support
from partner, surrogates’ perception of the extent to which the patient is reluctant to burden
others, extent to which surrogate has communicated with partner about end-of-life treatment
preferences, surrogates’ perceived similarity to patients on end-of-life values, and differences
between surrogates’ and patients’ perceived similarity on end-of-life values. Furthermore, this
study investigated whether accuracy and related variables differed across the vignettes, since
each vignette dealt with a different treatment intervention.
Surrogates’ accuracy on decision vignettes
In concordance with Hare and colleagues’ (1992) findings, and a preponderance of
evidence from the surrogate decision-making accuracy literature (Shalowitz, 2002; Spalding,
2020), surrogates predicted patients’ preferences with poor accuracy across the decision
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vignettes. Specifically, surrogates predicted preferences with accuracy that was significantly
worse than that which would be expected by chance alone. This finding adds to the body of
evidence suggesting that individuals who make decisions for patients in end-of-life situations
may not be trusted to consistently select the treatment that the patient would have wanted (Torke,
2008). The level of agreement found in the current study is notably lower than that reported in a
systematic review of the literature by Shalowitz et al. (2006; 68% agreement, on average), yet it
is consistent with levels reported by more recent investigations of surrogate decision-making
accuracy (e.g., Bravo et al., 2017).
Among pairs in which surrogates inaccurately predicted preferences on one or more
decisions, there was a tendency for surrogates to undertreat and fail to provide treatment that the
patient would have desired. Prior surrogate decision-making accuracy research has revealed
inconclusive patterns of surrogate inaccuracy; some studies have reported no differences in
overtreatment versus undertreatment errors (e.g., Moorman & Carr, 2008), while others have
documented a slight tendency for surrogates to overtreat (e.g., Fagerlin et al., 2001) and
undertreat (e.g., Bravo et al., 2017). The current findings are more consistent with literature
regarding discrepancies in estimating levels of pain or discomfort experienced by others. In
particular, the surrogate decision-making literature reflects that surrogates are only moderately
successful when gauging levels of pain experienced by the patients they serve (Desbiens &
Mueller-Rizner, 2000) and that surrogates tend to underestimate patients’ perceptions of an
acceptable quality of life (Bravo et al., 2017).
There are undoubtedly mediating and moderating factors that may influence surrogates’
propensities to undertreat. For instance, “empathy gaps” may inhibit the surrogate’s ability to
accurately adopt the perspective of the patient in a situation of critical illness or disability
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(Loewenstein, 2005). The concept of the “disability paradox” is relevant to the medical decisionmaking literature (Ubel et al., 2005) and speaks to the mechanism by which undertreatment
errors may occur, since individuals may fail to appreciate the ease with which others can adapt to
poor health conditions and situations of impairment or discomfort. Certainly, the issue of
undertreatment raises ethical issues that have prompted medical ethicists (e.g., Gillick & Fried,
1995) to advocate for revising standards of surrogate decision making beyond the substituted
judgment standard, perhaps more strictly enforcing a standard of “best interest” standard that
restricts surrogates from violating explicit treatment norms of the medical profession.
The discrepancy in treatment decisions between patients and surrogates is particularly
alarming given that surrogates reported that they felt they understood the costs and benefits
related to the vignettes relatively well, and that they had discussed end-of-life preferences with
patients to some extent. Prior research has documented a propensity for surrogates to reflect that
they feel more equipped to make decisions when they have discussed patients’ preferences in
advance (e.g., Batteux, Ferguson, & Tunney, 2020; Schenker et al., 2012). Engaging in prior
discussions may be associated with improved accuracy in some cases, but not all. Surrogates’
reports of prior discussions with patients predicted accuracy only for the decision vignette
pertaining to cardiac bypass surgery. Of the decision vignettes used in this study, the cardiac
bypass vignette also demonstrated the highest level of percent agreement between patients and
surrogates. Coronary artery bypass is among the most common surgical interventions performed
in the United States (Johns Hopkins Medicine, 2020) and participants may have had greater
familiarity with this procedure relative to the other interventions presented in the study. Research
indicates that patients who report greater familiarity with interventions, particularly those related
to cardiovascular surgery, seek more participation when making decisions pertaining to these
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interventions (Mansell et al., 2000). If cardiac bypass was an intervention for which patients and
surrogates had greater familiarity or held more similar preferences, surrogates may have been
more inclined to be accurate on this vignette. Prior discussions of preferences may have
particularly bolstered this effect.
However, the evidence regarding whether discussion-based interventions targeting endof-life preferences improves surrogate decision-making accuracy is mixed (Lord, Livingston, &
Cooper, 2015; Shalowitz, 2006). The current study further reflects how surrogates’ confidence in
the value of engaging in prior discussions about end-of-life care is not strongly tied to their
accuracy. An explanation for this occurrence may be that surrogates overvalue the degree to
which these conversations truly facilitate their abilities to execute the substituted judgment
standard and select the intervention that the patient would choose. For instance, surrogates may
report that they discuss end-of-life preferences quite frequently with patients, but these
conversations may lack the depth and specificity required to accurately identify a preferred
course of treatment. Hence, surrogates may misinterpret higher-frequency discussions as being
of higher-quality, producing an inflated assessment of one’s knowledge of treatment options and
patient preferences. Values related to end-of-life decisions are complex, and surrogates may
unwittingly adopt a myopic, oversimplified view of treatment decisions (Scheunemann & White,
2011). For instance, surrogates may fail to appreciate the number and variety of values
implicated in a treatment decision and focus too narrowly on a single identified value, such as
the desire to sustain life at any cost (Swindell, McGuire, & Halpern, 2010).
In light of evidence that surrogates’ approaches to decision making vary based on the
type of treatment decision being made (Spalding & Edelstein, 2020), accuracy was also
examined for each decision vignette individually. Patient-surrogate agreement was lowest for the
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decision concerning whether to provide ventilation, while it was highest for the decision
regarding coronary bypass surgery (see Table 3). Participants’ approaches to the decision
vignette regarding ventilation in particular must be considered in the unique context of the global
pandemic during which data collection occurred. COVID-19, a disease with symptoms primarily
affecting the respiratory system, can produce severe complications such as pneumonia that
require the use of mechanical ventilation (Dondorp et al., 2020). During the pandemic, estimates
of the number of needed ventilators in the United States ranged from several hundred thousand
to over one million (Fink, 2020). The country’s insufficient ability to meet this demand was
well-broadcast and concerns for the adequate provision of critical care supplies were raised
(Ranney et al., 2020). Such heightened public attention towards mechanical ventilation may have
prompted participants to reexamine their views towards this treatment option in particular, such
that patients’ personal desires to receive ventilation may have shifted, unbeknownst to their
surrogates. Therefore, surrogates may have been less accurate on this decision because they
chose decisions based on understandings of what patients may have selected before the
pandemic, knowledge of how patients’ views towards this treatment option may have changed
due to recent circumstances.
Variables related to overall accuracy on decision vignettes
Several interesting relations emerged to enhance understandings of potential mechanisms
underpinning surrogates’ accuracy. Specifically, the following were associated with accuracy:
surrogates’ trust, empathy, religiosity, perceived similarity on end of life values, and perceptions
of patients' reluctance to burden others. Differences between surrogates and patients on end-oflife values was also associated with accuracy. When taken altogether, these variables
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significantly predicted surrogates’ accuracy when completing hypothetical decision tasks,
although none of the variables were unique predictors.
The relation between agreement and empathy is consistent with understandings of
empathy as a construct that promotes perspective-taking (Lamm et al., 2007). Moreover, the
observed role of empathy may have been particularly pronounced given the age of the recruited
sample (Mage = 47 years for patients, 51 years for surrogates), as empathy tends to peak in
middle-adulthood (O’Brien et al., 2013), the life stage that characterized the majority of the
current sample.
The importance of interpersonal empathy, as identified by the current study, contributes
to understandings of “cold to hot” interpersonal empathy gaps that may occur when individuals
make medical decisions on behalf of others. “Cold to hot” empathy gaps refer to a situation in
which a person is in an emotionally “cold” or neutral state and attempts to make a decision or
prediction about behaviors, preferences, or feelings that may occur in a future emotionally “hot”
state (Loewenstein, 2005). In medical decision making, this type of empathy gap can result in the
treatment decision-maker underappreciating the amount of pain and discomfort experienced by a
patient. This phenomenon has most often been investigated to the extent that it applies to
physicians’ tendencies to undertreat patients’ pain (Loewenstein, 2005), but surrogates could
also fall prey to interpersonal empathy gaps and select less intensive treatment interventions than
the patient would have desired. As suggested by the current study, surrogates with lower levels
of empathy might consequently be less accurate when predicting patient preferences. Indeed,
among surrogates who inaccurately predicted preferences on one or more decision scenarios,
there was a tendency to err by undertreating. Therefore, empathy may have been a source of this
discrepancy, which warrants examination in future work.
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Accuracy was also positively correlated with religiosity, such that surrogates with greater
self-reported religiosity were more accurate when predicting preferences. This is the first study
to specifically examine religiosity relative to surrogate decision-making accuracy. Although
religiosity was not significantly correlated with empathy, which may have illustrated a
mechanism by which surrogates higher in religiosity were better able to predict preferences, an
alternative explanation for this relation could lie in previously demonstrated positive associations
between religiosity and personality variables not assessed by the current study, such as
conscientiousness (Henningsgaard & Arnau, 2008). Surrogates who report greater religiosity
may be those who are more conscientious, and who therefore completed the decision activity
with greater care and attention to patient preferences. Some evidence suggests inverse
associations between surrogates’ religiosity and patients’ receipt of life-sustaining treatments
(Torke et al., 2020), such that surrogates who endorse greater religiosity are less likely to select
life-sustaining treatments for patients. This correlation pattern was not evident when religiosity
was examined relative to surrogates’ intervention selections on decision vignettes.
Rather, the current findings are more consistent with evidence from the religious coping
literature that illustrates associations between religious coping behaviors, such as seeking support
through faith communities during times of stress, and end-of-life treatment. For instance, Phelps
and colleagues (2009) found that advanced cancer patients who reported strong engagement in
religious activities to cope with their illness were more likely to receive intensive life-prolonging
treatments at end-of-life. Of note, this study examined patients’ reports of their own participation
in religious coping. Relations between surrogates’ religious coping behaviors while serving as a
surrogate and the decisions they make on the patient’s behalf have not yet been determined.
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Surrogates who were more accurate predictors of patient preferences also tended to be
those who reported greater trust in the medical profession. Theoretical conceptualizations of
surrogate decision making have proposed that low trust in the medical profession may hinder
surrogates’ decision making and reduce the overall quality of their decisions (e.g., Meeker, 2004;
Torke et al., 2014). As the first investigation to specifically examine trust in the medical
profession as it relates to surrogate decision-making accuracy, the current study provides
preliminary support for these conjectures.
Perceiving the patients’ values as more similar to one’s own (as measured by ratings on
the Quality of Life and Life Values Index) was also associated with surrogates’ accuracy. This is
consistent with prior research evaluating surrogates’ execution of the substituted judgment
standard and their reflections of the process, such that surrogates often state that they rely on
known mutual interests between themselves and the patient to guide their decisions (Vig et al.,
2006). However, other researchers caution that high perceived similarity can undermine decision
making if surrogates mistakenly interpret their own values as identical to those of the patient
(Fagerlin et al., 2002). Contrary to findings by Winter and Parks (2012), differences in
surrogates’ estimates of patients’ reluctance to burden others and patients’ own self-reported
levels of reluctance were not associated with accuracy.
Variables related to accuracy on individual decision vignettes
Although the regression model predicting accuracy as computed across all decision
vignettes was not significant, the variables did predict accuracy for certain vignettes when they
were examined individually. Specifically, the predictive model was significant for decisions
regarding the provision of ventilation, dialysis treatment, and cardiac bypass surgery. This
finding aligns with previous work (Spalding & Edelstein, 2020) reflecting how treatment options
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may differentially evoke certain decision-making approaches by surrogates, in terms of their
desire to collaborate with patients’ physicians and assume full responsibility for decisions. These
differences may be due to the fact that presented treatments differ in the amount of risk they
involve, and the extent to which such risk is considered worthwhile in the context of the decision
(Sitkin & Weingart, 1995). For instance, when making decisions about treatments that confer
more immediate and substantial risks (e.g., CPR, which presents associated risks of broken ribs
and punctured lungs, but which will likely result in immediate death if not provided), the degree
of confidence a surrogate has in their decision-making ability is associated with the extent to
which they desire collaboration with providers (Spalding & Edelstein, 2020).
With regard to the decision pertaining to mechanical ventilation, surrogates’ empathy and
perceived similarity to patients on key values emerged as unique predictors of agreement on
decisions. This is consistent with prior findings such as those from McDade-Montez, Watson,
and Beer (2013), reflecting that spouses who perceive greater similarities to their partners on
values pertaining to end-of-life tend to be more accurate when predicting partners’ treatment
preferences. For the dialysis treatment decision vignette, surrogates who reported less
willingness to take full responsibility for medical decisions were more likely to accurately
predict patient preferences. This finding is concerning if surrogates who are more likely to defer
decision making to providers are those who actually better understand patients’ preferences, and
who would make a decision in closer alignment with patient preferences. However, the current
study cannot provide behavioral evidence as to whether surrogates’ decision-making behaviors
match their preferences for decisional responsibility. In other words, despite feeling
uncomfortable with the decisional role, surrogates may nonetheless make decisions for patients
without deferring to a provider in real treatment decision situations. This would be consistent
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with reports that observed communication behaviors between patients and providers do not differ
significantly based on patients’ reported communication preferences (Kumar et al., 2010).
Lastly, as previously discussed, surrogates’ reports of prior engagement in discussions of
end-of-life preferences with their partners predicted greater accuracy on the cardiac bypass
decision vignette. This relation corroborates prior findings that such discussions tend to improve
surrogates’ decision making, as measured both by surrogates’ self-reported ease with decision
making and the accuracy of the decisions they made when compared to those of their partners
(e.g., Batteux, Ferguson, & Tunney, 2020). Similar to relations observed for the mechanical
ventilation vignette, greater empathy and perceived similarity to patients on end-of-life values
was associated with an increased likelihood of agreement on the cardiac bypass decision.
Variables related to intervention selection
Given that the main regression analysis predicting agreement scores was not significant,
an exploratory analysis investigated the predictive role of the interpersonal and intrapersonal
variables with respect to surrogates’ treatment choices on the decision vignettes. In other words,
these variables were used to predict surrogates’ tendencies to approve treatment administration.
It is noteworthy that the interpersonal and intrapersonal variables significantly predicted
treatment selection, F (16) = 2.28, R2 = .24, p = .006. Of the predictor variables, the only unique
predictor was COVID-19-related anxiety (β = .28, p < .005) such that surrogates with greater
anxiety about COVID selected more intensive treatments for patients.
Although current understandings of COVID-19-related anxiety are nascent, this specific
type of anxiety demonstrates positive relations with anxiety and depressive disorder symptoms
(Asmundson et al., 2020), which was also evident in the current study (see Table 4). Moreover,
anxiety about COVID appears to be associated with feelings of hopelessness and the use of
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maladaptive coping mechanisms (e.g., drugs and alcohol; Lee, 2020). Importantly, these negative
emotions and coping behaviors pertain to oneself and one’s current situation, not involving
another person. In the current study, surrogates were acting on behalf of another person to whom
they were presumably close. Evidence from the self-other decision-making literature reflects that
individuals often choose different decisions for another person than they would for themselves;
for instance, they are more likely to make a “safer” choice than they would for themselves in
situations where risk aversion is valued (Stone et al., 2013). Therefore, surrogates may have
chosen an intensive treatment intervention to “save” the patient in these vignettes, despite feeling
pessimistic about their personal circumstances in the emotionally distressing context of a global
pandemic. Ultimately, more research is needed regarding the relation between perceptions of
COVID and treatment preferences, specifically with regard to self-other decision-making
discrepancies.
Limitations and Future Directions
As with any study, limitations exist. First, hypothetical scenarios can only model a realworld decision-making scenario, and these findings are therefore limited with respect to
generalizability. For instance, surrogates may be vulnerable to a “cold-to-hot” empathy gap
(Loewenstein, 2005) when completing hypothetical medical decision vignettes, such that they
underestimate the force of motivational and affective pressures that occur in the emotionally
“hot” conditions of a real treatment decision situation. However, logistical constraints of
gathering data at the exact moment at which surrogate decision making takes place, particularly
during a pandemic that limited access to healthcare facilities, impeded this possibility. Related to
the design of this study, a common concern raised with regard to hypothetical surrogate decisionmaking tasks is the fact that surrogates may struggle with the perspective-taking effort required.
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For instance, surrogates may misread or misunderstand the instructions of the decision task and
make decisions more in accordance with their own preferences. However, this issue is a concern
in real-life surrogate decision-making situations (Marks & Arkes, 2008), and the design of the
current study permitted the evaluation of this tendency by assessing agreement between patients
and surrogates on the vignettes.
Of further relevance to generalizability, limitations exist with respect to certain features
of the recruited patient-surrogate dyads. The majority of pairs in the current study were those in
which a female was serving as a surrogate on behalf of a male patient, most often in the context
of a spousal or romantic partnership. As previously described, gender differences in medical
surrogate decision-making accuracy among marital partners have been documented, such that
wives tend to be more accurate than their husbands in hypothetical surrogate decision making
scenarios (Zettel-Watson et al., 2005). Therefore, the level of agreement on surrogate decisionmaking tasks reported by the current study may overestimate that which occurs in surrogate
decision-making situations featuring a male surrogate serving on behalf of female patients.
With respect to demographic characteristics, participants were relatively well-educated,
in generally good health, and identified as White/Caucasian. As such, the recruited sample
underrepresents the diverse population of patients, and their associated surrogates, who are
encountered in United States intensive care units where end-of-life surrogate decision-making
often occurs (Barker, 2006). Patient-surrogate pairs of minority backgrounds are important to
investigate, as medical decision-making tendencies can vary considerably across groups. For
instance, among Black and Latinx individuals, those who reported a lower level of educational
attainment preferred more intensive medical treatment options (Volandes, Ariza, et al., 2008;
Volandes, Pasche-Orlow, et al., 2008). Alarmingly, patients of racial and ethnic minority
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backgrounds tend to receive end-of-life care that is inconsistent with their stated preferences
(Mack et al., 2010) and families of these individuals demonstrate greater conflict and discord
during the end-of-life decision-making process (Muni et al., 2011). Among patients in intensive
care units, those with limited English proficiency also have lower rates of advance directive
completion, necessitating the consultation of a surrogate if one is available (Barwise et al., 2018),
and tend to receive more aggressive end-of-life treatment (Yarnell et al., 2017).
To improve generalizability, future investigations may prioritize investigating surrogate
decision-making accuracy with different combinations of patient-surrogate relationships. These
might include pairs of siblings, grandparents and grandchildren, close friends, and more distant
relatives. Most of the pairs recruited for the current study were spouses or romantic partners.
Spousal and romantic relationships are presumably quite close in terms of emotional intimacy
and familiarity. Research investigating actor-partner models of decision making indicates that
pairs who report greater feelings of familiarity form more positive appraisals of the decisionmaking process when collaborating on decisions with each other (Margrett & Marsiske, 2002).
This may translate into the realm of surrogate decision making such that pairs who feel closer to
one another are more comfortable with making decisions on each other’s behalf and be more
likely to agree with each other on decisions. In one investigation of a communication
intervention designed to improve patient-surrogate agreement on end-of-life decisions
(SUPPORT, Marbella et al., 1998), the intervention actually reduced agreement among pairs
who were not immediate family members, indicating that communication about decisions
operates differently for these types of pairs. Future work might examine this issue more closely,
perhaps with the aim of generating decision support tools for patient-surrogate pairs who are
more distantly related.
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Future investigations could investigate relations reported by the current study with
attention to the potential involvement of mediating or moderating variables. Although not
assessed by the current study, the role of surrogates’ personality characteristics bears
consideration in light of evidence from the patient medical decision-making literature. For
instance, patients with high levels of conscientiousness and openness tend to prefer more active
involvement in decision making (Djanetliev & German, 2013), while those who score low in
extraversion report feeling dependent on a provider’s expertise and are more likely to defer
decision-making authority (Shay & Lafata, 2014). Neurotic patients also report greater anxiety
associated with medical decision making (Weston, Hill, & Jackson, 2015) and tend to choose
less risky treatment options (Lauriola & Levin, 2001). The extent to which these relations are
similar for surrogates, and may influence their accuracy when predicting patient preferences, has
yet to be examined.
Gender differences in surrogate decision-making accuracy also warrant exploration,
perhaps to investigate whether surrogates are more accurate when predicting preferences for a
patient who identifies as the same gender. Further, given that male patients are more likely to
prefer intensive treatment options than females (Bookwala et al., 2001), the extent to which
similar differences exist for surrogates when choosing treatments for patients could be examined.
Additionally, in light of findings from this study indicating that surrogates may differ in the
extent to which they “overtreat” or “undertreat” when selecting treatments for patients, future
research could further explore variables related to overtreating or undertreating tendencies.
Ultimately, such findings could be used to specifically classify “types” of surrogate decision
makers, in order to allow providers to better anticipate the interventions surrogates may choose
and assist them with the decisional process accordingly.
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With regard to measurement techniques, work conducted during the COVID-19
pandemic may prioritize the psychometrically sound assessment of COVID-19-related anxiety, a
variable with demonstrated importance in the current study. At the time of study design, no
validated assessment measures of this construct existed, and a single-item measure was
subsequently used. Since completion of data collection, researchers have begun to design and
validate assessment measures to more comprehensively capture COVID-19-related anxiety. In
particular, the five-item Coronavirus Anxiety Screener (Lee, 2020) demonstrates good reliability
and validity evidence and would be a valuable resource for use in future studies. The extent to
which COVID-19-related anxiety differs from health anxiety more generally also merits further
exploration.
Finally, research employing hypothetical surrogate decision-making vignettes might
examine the extent to which surrogates have engaged in discussions with patients for specific
decisions. In the current study, surrogates’ accuracy and self-reported levels of treatment
understanding were not consistent across the decision vignettes. Pairs may discuss more
commonly administered interventions (e.g., CPR, coronary bypass surgery) with greater
frequency and detail than others. These findings speak to the importance of considering decisionspecific support for surrogates when making decisions on behalf of patients. For instance, ample
patient decision guides and tools exist to aid with medical decisions, such as those relating to
mechanical ventilation or dialysis (e.g., Mayo Clinic Shared Decision Making Resource Center;
see Cardona-Morrell et al., 2017 for a review), and could be similarly adapted for use with
surrogates. When creating decision support tools, providers may also con
Conclusions

54
The current study further amplifies concerns for surrogates’ accuracy, and their ability to
execute the substituted judgment standard, by revealing inconsistencies in patient-surrogate
agreement when selecting treatment interventions. Certain interpersonal and intrapersonal
variables, as reported by surrogates, predicted accuracy across all decision vignettes. These
variables include surrogates’ religiosity, trust in the medical profession, empathy, perceived
similarity to patients on values related to end-of-life, and perceptions of patients as being more
reluctant to burden others. Examination of accuracy for individual decision vignettes provided
further evidence that surrogate medical decision making varies based on the type of treatment
decision that is being made.
The selected variables in this study significantly predicted surrogates’ intervention
selections on behalf of patients. Of the predictor variables, surrogates with greater anxiety about
COVID selected more intensive treatments for patients. Findings from this broad, exploratory
study can be used to further the development of targeted decision-making interventions to
improve surrogates’ accuracy. Providers may attend to these variables when working with
surrogates in their decision-making role. For instance, during the current pandemic, providers
may specifically attend to facilitating surrogates’ trust in the medical profession and ability to
cope with anxiety surrounding COVID-19.
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Appendix A
Demographic Questionnaire
Name: ________________
Age: ______
Sex: (choose one)
Male Female Transgender Female Transgender Male Gender Non-conforming
Years of Education: _____
Marital Status: (choose one)
Single
Married/Committed Relationship

Separated

Divorced

Widowed

Ethnicity: (choose all that apply)
Caucasian/White
African American/Black
Asian American
Hispanic/Latino
Pacific Islander
Native American (American Indian/Alaskan Native)
In what geographic region of the United States do you live?
Northeast
Southeast
Midwest
Southwest
Northwest
Do you have health insurance?
Yes No
How would you rate your physical health, overall?
Poor Fair Good Very good
Excellent
Have you heard of COVID-19 (coronavirus)?
Yes No
To what extent are you worried about COVID-19?
Not at all (1) 2 3 4
Moderately (5) 6 7 8 9 Very much (10)

In this study, both you and another individual from your life will be participating. What is your
relationship to this person? (choose one)
Spouse/partner Sibling Parent

Adult child Close friend

Other family member
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To what extent have you talked with this person about end-of-life decisions, including personal
preferences?
Not at all

A little

Moderately

Very much

For this study, it is important that you do not discuss the contents of this survey with this person.
By typing your full name in the space provided, you agree that you will not discuss any portion
of this survey with this person: _________________
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Appendix B
Decision Task (from Hare et al., 1992)
Surrogate Instructions: When reading the following vignettes, please imagine the person you
identified on the demographic questionnaire is the patient. Also imagine that you are formally
serving in a surrogate decision-making role where a healthcare provider is asking you to give
instructions. When making these decisions, please make the decision that you think the patient
would choose.
Note: use of the word “you” and “the patient” in the vignettes will vary based on survey version
(patient or surrogate), as indicated by italics. Respondents’ choice options for each decision
are indicated in bold text.
Part A: Ventilation
Sometimes when a patient cannot breathe on his/her own, a tube is placed down the windpipe of
the patient and attached to a breathing machine, which can either totally or partially take over
breathing for the patient. The following case is about a woman who cannot breathe on her own.
Mrs K. is a woman the patient’s/your age who has recently suffered a major stroke, leaving her
in a coma and unable to breathe without a machine. After a few weeks, the doctor tells you that it
is unlikely that Mrs K. will come out of the coma and that no one can be certain what her level of
functioning would be if she ever did come out of the coma. What if this were the patient/you and
the doctor asked you whether the breathing machine should be removed or continued? What
would you say? (Remove/Continue)
To what extent do you feel you understand the costs and benefits associated with this treatment?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel that your family and friends find this treatment acceptable?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much

Part B: Resuscitation
If a patient's heart or breathing stops while in the hospital, an emergency team will be called to
try to get the heart and lungs started again. This is called CPR (resuscitation).
Again, think of the first case. Suppose the doctor wanted to know whether to try to resuscitate
the patient/you if their/your heart stopped beating? What would you say? (Do not attempt
CPR/Attempt CPR)
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To what extent do you feel you understand the costs and benefits associated with this treatment?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel that your family and friends find this treatment acceptable?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much

Part C: Tube feeding
A patient who cannot eat can be fed through a nasogastric (NG) tube. This tube is placed down
the nose and through the esophagus into the stomach. High-energy liquid foods are delivered
down the tube. Often the patient has some diarrhea for the first week or two because of the
different type of food that is being digested. Other types of artificial feeding methods that can be
used are intravenous lines or a tube placed through the belly wall into the stomach.
Think of Mrs K. again. Because Mrs K. cannot eat or drink, she must be given artificial nutrition
and hydration to keep her alive. A feeding tube may keep her alive perhaps for many more years.
If this were the patient/you would you or would you not have the feeding tube placed? (No/Yes)
To what extent do you feel you understand the costs and benefits associated with this treatment?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel that your family and friends find this treatment acceptable?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much

Part D: Chemotherapy
Mr. L. is a man the patient’s/your age who has been diagnosed as having a type of cancer that
probably cannot be cured. Because of mental confusion, Mr L. cannot make medical decisions
on his own. His doctor recommends to you that chemotherapy be started. The doctor explains
that the chances of curing Mr L. are very small but that the chemotherapy may help him live
longer. You are also told about the side effects of chemotherapy, which can make a patient very
ill. What if this were the patient/you? What would you tell the doctor to do? (Do not begin
chemotherapy/Begin chemotherapy)
To what extent do you feel you understand the costs and benefits associated with this treatment?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel that your family and friends find this treatment acceptable?
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Not at all

A little

Somewhat

Moderately

Very much

To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much

Part E: Amputation
Mr. S. is a man the patient’s/your age who has for many months been unable to make medical
decisions for himself because he has become mentally confused. Because of diabetes, he has
developed gangrene, or blood poisoning, in his leg. The doctor recommends that unless Mr. S.
has his leg removed, he will almost certainly die in a very short time. If the leg is not amputated,
medications can be given to control the pain, but he would almost surely die in a matter of days
from the blood poisoning. What if this were the patient/you? What would you tell the doctor to
do? (Do not amputate/Amputate)
To what extent do you feel you understand the costs and benefits associated with this treatment?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel that your family and friends find this treatment acceptable?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much

Part F: Coronary Artery Disease— Bypass Surgery
Bypass surgery helps improve blood flow to the heart in people with severe heart disease. Bypass
surgery might improve your chances of living a longer life. Most of the time, bypass surgery is
open-chest surgery. It can ease symptoms, such as chest pain and shortness of breath. For some
people, this procedure can improve heart function and reduce the risk of dying of heart disease.
Although complications from bypass surgery are uncommon, risk is a part of every surgical
procedure. Potential risks include wound infection and bleeding, adverse reactions to anesthesia,
fever, pain, stroke, heart attack, or even death. Bypass surgery is not a cure for heart disease. The
surgery doesn't change the way arteries harden or narrow because of heart disease. Even after
surgery, you can still get new places in your arteries that are narrowed, so you will still need to
continue medicines and lifestyle changes to give you the best chance of living a longer, healthier
life.
Suppose that the patient/you has started experiencing some symptoms of chest pressure and
shortness of breath at times. Your doctor gives you some tests and diagnoses you/the patient with
severe heart disease and says that you should consider bypass surgery as a treatment option.
Would you choose for yourself/the patient to have the surgery? (Have bypass/Do not have
bypass)
To what extent do you feel you understand the costs and benefits associated with this treatment?
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Not at all

A little

Somewhat

Moderately

Very much

To what extent do you feel that your family and friends find this treatment acceptable?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much

Part G: Chronic Kidney Disease—Dialysis Treatment
Chronic kidney disease (CKD) is a long-term health problem where the kidneys slowly stop
working. Over time, the damaged kidneys may stop working altogether. When the kidneys work
less than about 10-15% of their normal rate, the kidney disease is described as established kidney
disease (EKD). There is no cure for people with established kidney disease. Once people have
established kidney disease, they have it for the rest of their life.
Dialysis is a treatment for established kidney disease that uses equipment to clean your blood
and do some of the work that healthy kidneys do. Patients usually receive three dialysis
treatments per week, and each treatment session usually takes at least 3 hours to complete.
Dialysis does about 10% of the work of healthy kidneys and improves some of the symptoms of
kidney disease, but does not cure the chronic kidney disease. Failing kidneys will keep getting
worse. Most people with established kidney failure who have dialysis treatments live longer than
people who do not. Without treatment, the average life expectancy for a person diagnosed with
established kidney failure is 6 months, whereas the average life expectancy of a person receiving
dialysis treatment is about 4 years. Once a person begins dialysis treatment, they will need to
have dialysis for the rest of their lives, or until they have a successful kidney transplant.
There are some common problems people may get when they have dialysis including fatigue,
dizziness, and adjusting to the dialysis routine. All people having dialysis are seen by a specialist
team at hospital, and in their homes, to help make the changes needed to their food, drink, and
medicines.

Suppose that the patient/you has a diagnosis of established kidney disease. The doctor presents
dialysis treatment as the next treatment option that you/the patient could seek at this time. Would
you choose for yourself/the patient to begin dialysis treatment? (Begin dialysis/Do not begin
dialysis)
To what extent do you feel you understand the costs and benefits associated with this treatment?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel that your family and friends find this treatment acceptable?
Not at all
A little
Somewhat
Moderately Very much
To what extent do you feel confident in this decision?
Not at all
A little
Somewhat
Moderately

Very much
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Appendix C
Trust in the Medical Profession Scale (TIMPS; Hall et al., 2002)
Please use the below scale to indicate how much you agree with each statement.
1
(strongly disagree)

2

3
(neither agree nor disagree)

4

5
(strongly agree)

1. Doctors in general care about their patients’ health just as much or more than their patients
do.
2. Sometimes doctors care more about what is convenient for them than about their patients’
medical needs.
3. Doctors are extremely thorough and careful.
4. You completely trust doctors’ decisions about which medical treatments are best.
5. Doctors are totally honest in telling their patients about all of the different treatment
options available for their conditions.
6. Doctors think only about what is best for their patients.
7. Sometimes doctors do not pay full attention to what patients are trying to tell them.
8. Doctors always use their very best skill and effort on behalf of their patients.
9. You have no worries about putting your life in the hands of doctors.
10. A doctor would never mislead you about anything.
11. All in all, you trust doctors completely.
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Appendix D
Communication-Based Emotional Support Scale (CBESS; Weber & Patterson, 1996)
Please use the below scale to indicate how much each statement is true of you, in general, with
regard to your partner in this study.
1
2
3
4
5
(almost never true) (rarely true) (occasionally true) (often true) (almost always true)
1. My partner helps me work through my thoughts and feelings about major life decisions
(e.g., career choices).
2. My partner patiently and sensitively listens to me “let off steam” about an outside problem
that I am having.
3. When I tell my partner about a problem I am having, they don’t seem to be paying
attention.
4. My partner helps me cope with problems concerning other friends or family members.
5. My partner avoids me when I am depressed.
6. My partner is good listeners when I am upset.
7. When I am feeling down, my partner can say and do supportive things.
8. When I want to talk to someone about something that is bothering me, my partner seems
to have something else to do.
9. My partner shows genuine concern for my problems.
10. My partner gives me good advice when I ask for it.
11. My partner makes it easy to discuss my personal feelings.
12. My partner listens to my side of the story even when they think that I am wrong.
13. My partner makes an effort to make me feel better when I am depressed.
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Appendix E
Center for Epidemiological Studies Depression Scale-Revised (CESD-R; Eaton et al., 2004)
Please use the below scale to indicate how frequently you experienced each of the following
symptoms over the past two weeks.
1
(not at all or < 1 day)

2
(1-2 days)

3
(3-4 days)

1. My appetite was poor
2. I could not shake off the blues.
3. I had trouble keeping my mind on what I was doing.
4. I felt depressed.
5. My sleep was restless.
6. I felt sad.
7. I could not get going.
8. Nothing made me happy.
9. I felt like a bad person.
10. I lost interest in my usual activities.
11. I slept much more than usual.
12. I felt like I was moving too slowly.
13. I felt fidgety.
14. I wished I were dead.
15. I wanted to hurt myself.
16. I was tired all the time.
17. I did not like myself.
18. I lost a lot of weight without trying to.
19. I had a lot of trouble getting to sleep.
20. I could not focus on the important things.

4
(5-7 days)

5
(nearly every day)
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Appendix F
Life Values Inventory (LVI; Schonwetter et al., 1996)
Below are some values that individuals may find important to them with regard to medical
decision making at end-of-life. Please use the below scale to indicate the extent you think that
your partner’s values are similar to your own.
1
(exactly the opposite of me)

2

3
4
(somewhat similar to me)

5
(exactly the same as me )

1. To preserve good quality of life, even if one doesn’t live as long.
2. To live as long as possible, regardless of the quality of life.
3. To maintain the capacity to think clearly.
4. To feel safe and secure.
5. To be able to make one’s own decisions.
6. To avoid being a burden on one’s family.
7. To leave good memories of one’s last days to loved ones.
8. To be with loved ones before dying.
9. To avoid pain and suffering.
10. To experience a comfortable dying process.
11. To be treated with dignity when unable to speak for oneself.
12. To be treated with respect.
13. To be treated in accordance with one’s religious beliefs.
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Appendix G
Quality of Life Values Inventory (QLVI; Cohen-Mansfield, Droge, & Billig, 1992)
For each of the following values statements, please use the scale below to indicate the extent to
which you think that your partner’s values are similar to your own.
1
(exactly the opposite of me)

2

3
4
(somewhat similar to me)

5
(exactly the same as me )

1. I’d rather not live than be a burden on anyone else.
2. Quality of life is more important than preservation of life.
3. At the end of my life, other people will have the right to live their own lives; they will
have taken care of me long enough.
4. Life must be preserved at any cost.
5. At the end of my life, I should think of myself first; if I need help, others will take care of
me.
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Appendix H
Interpersonal Reactivity Index (IRI; Davis, 1980)
Please use the below scale to indicate how much you agree with each statement.
1
2
3
4
5
(strongly disagree)
(neither agree nor disagree)
(strongly agree)
1. When I am reading an interesting story or novel, I imagine how I would feel if the events in
the story were happening to me.
2. I really get involved with the feelings of the characters in a novel.
3. I am usually objective when I watch a movie or play, and I don’t often get completely
caught up in it.
4. After seeing a play or movie, I have felt as though I were one of the characters.
5. I daydream and fantasize, with some regularity, about things that might happen to me.
6. Becoming extremely involved in a good book or movie is somewhat rare for me.
7. When I watch a good movie, I can very easily put myself in the place of a leading
character.
8. Before criticizing somebody, I try to imagine how I would feel if I were in their place.
9. If I’m sure I’m right about something, I don’t waste much time listening to other people’s
arguments.
10. I sometimes try to understand my friends better by imagining how things look from their
perspective.
11. I believe that there are two sides to every question and try to look at them both.
12. I sometimes find it difficult to see things from the “other guy’s” point of view.
13. I try to look at everybody’s side of a disagreement before I make a decision.
14. When I’m upset at someone, I usually try to “put myself in his shoes” for a while.
15. When I see someone being taken advantage of, I feel kind of protective toward them.
16. When I see someone being treated unfairly, I sometimes don’t feel very much pity for
them.
17. I often have tender, concerned feelings for people less fortunate than me.
18. I would describe myself as a pretty soft-hearted person.
19. Sometimes I don’t feel sorry for other people when they are having problems.
20. Other people’s misfortunes do not usually disturb me a great deal.
21. I am often quite touched by things that I see happen.
22. When I see someone who badly needs help in an emergency, I go to pieces.
23. I sometimes feel helpless when I am in the middle of a very emotional situation.
24. In emergency situations, I feel apprehensive and ill-at-ease.
25. I am usually pretty effective in dealing with emergencies.
26. Being in a tense emotional situation scares me.
27. When I see someone get hurt, I tend to remain calm.
28. I tend to lose control during emergencies.
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Appendix I
Health Opinion Survey (HOS; Krantz, Baum, & Wideman, 1980)
Please use the below scale to indicate how much you agree with each statement.
1
(strongly disagree)

2

3
(neither agree nor disagree)

4

5
(strongly agree)

1. Except for serious illness, it’s generally better to take care of your own health than to seek
professional help.
2. It is better to rely on the judgements of doctors (who are the experts) than to rely on
“common sense” in taking care of your own body.
3. Clinics and hospitals are good places to go for help since it’s best for medical experts to
take responsibility for health care.
4. Learning how to cure some of your own illness without contacting a physician is a good
idea.
5. It’s almost always better to seek professional help than to try to treat yourself.
6. Learning how to cure some of your illnesses without contacting a physician may create
more harm than good.
7. Recovery is usually quicker under the care of a doctor or nurse than when patients take
care of themselves.
8. If it costs the same, I’d rather have a doctor or nurse give me treatments than to do the
same treatments myself.
9. It is better to rely less on physicians and more on your own common sense when it comes
to caring for your body.
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Appendix J
Reluctance to Burden Others Scale (RBO; Winter & Parks, 2012)
Below are some values that individuals may find important to them with regard to medical
decision making at end-of-life. Please use the below scale to indicate the extent you think that
your partner feels these are important.
1
(not at all important)

2

3
(somewhat important)

4

5
(very important)

1. Avoiding burdening family and friends emotionally as a result of medical treatment
decisions
2. Avoiding burdening family and friends financially as a result of medical treatment
decisions
3. Avoiding being dependent on others.
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Appendix K
Correlations between social norms, decision-making confidence, agreement scores, and
intervention scores
Social
Norms
Social Norms
Decision-making
Confidence
Agreement Score
Intervention Score

Decision-making
Confidence
.11

.11
.20*
.33**

.13
.07

Agreement
Score
.20*
.13

Intervention
Score
.33**
.07
.41**

.41

**

Note. **. p < .01 (2-tailed)
*
p < .05 (2-tailed)
Intervention Score = higher scores indicate stronger preferences for intensive interventions
Social Norms = higher scores indicate perceiving interventions as more socially acceptable among one’s family and
friends

Table 1
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Surrogate demographic characteristics.
Characteristic

N

%

Female

116

75.3%

Male

38

24.7%

131

85.1%

Black/African-American

9

5.8%

Asian-American

9

5.8%

Hispanic

3

1.9%

Native American/Pacific Islander

1

.6%

Mixed

1

.6%

Agnostic

4

2.6%

Atheist

9

5.8%

Christian

89

57.8%

Jewish

3

1.9%

Muslim

3

1.9%

Other

4

2.6%

Protestant

5

3.2%

Roman Catholic

29

18.8%

Seventh-Day Adventist

2

1.3%

Spiritual but not religious

5

3.2%

Sex

Race/ethnicity
White/Caucasian (not Hispanic)

Religion
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Marital Status
Single

9

5.8%

139

90.3%

Divorced

2

1.3%

Separated

1

.6%

Widowed

3

1.9%

Married/committed relationship

Table 2
Patient demographic characteristics.
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Characteristic

N

%

Female

44

28.8%

Male

109

71.2%

132

86.3%

Black/African-American

7

4.6%

Asian-American

10

6.5%

Hispanic

2

1.3%

Native American/Pacific Islander

1

.7%

Mixed

1

.7%

Agnostic

6

3.9%

Atheist

14

9.2%

Christian

89

58.2%

Jewish

1

.7%

Muslim

4

2.6%

Other

2

1.3%

Protestant

9

5.9%

Roman Catholic

22

14.4%

Seventh-Day Adventist

3

2.0%

Spiritual but not religious

3

2.0%

Sex

Race/ethnicity
White/Caucasian (not Hispanic)

Religion

97

Marital Status
Single

6

3.9%

134

87.6%

Divorced

7

4.6%

Separated

3

2.0%

Widowed

3

2.0%

Married/committed relationship
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Table 3
Percent of patient-surrogate pairs who agreed on each decision vignette.
Treatment Vignette

% Agreement

Ventilation

75.6%

CPR

83.6%

Feeding Tube

76.1%

Chemotherapy

81.3%

Amputation

82.8%

Cardiac Bypass

88.8%

Dialysis

85.1%
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Table 4
Correlations between surrogate intrapersonal and interpersonal variables, agreement scores, and intervention selection.

Agreement
Age
Physical
Health
Education
COVID
worry
QLVI/LVI
QLVI/LVI
Diff.
HOS
TIMPS
STAI
IRI
CESD
DUREL
RBO
CBESS
Tx Under
Intervention
Score
Tx Disc

Agreement

Age

Physical
Health

Education

COVID worry

QLVI/LVI

HOS

TIMPS

STAI

IRI

CESD

DUREL

RBO

CBESS

Tx Under

Tx Disc

Intervention
Score

1
-.02

-.02
1

-.00
-.09
1

-.08
.12

.09
-.10

.26**
-.10

.03
.06

.17*
-.02

.06
-.20*

.25*
.15

.10
-.10

.24**
.02

.18*
.07

.05
-.04

.10
.00

.12
.05

.41**
-.13

-.08
.09

-.08
-.10

-.04
-.04

1
-.12

-.12
1

-.08
.02

-.03
.05

-.06
.16*

-.05
.30**

-.16
.11

-.10
.31**

-.03
-.16*

.01
-.03

-.08
-.06

-.11
-.15

-.20*
-.16*

-.05
.24**

.26**
.22**

-.10
-.13

.06
.03

-.08
-.07

.02
-.04

1
.71**

-.25**
-.24**

.42**
.15

-.26**
-.21*

.57**
.50**

-.24**
-.32**

.23**
.20*

.64**
.44**

.57**
.41**

.36**
.31**

.20**
.12

.06
-.01

.03
.17*
.06
.25**
.10
.24**
.18*
.04
.09
.41**

.06
-.02
-.20*
-.15
-.10
.02
.07
-.04
.00
-.13

-.17*
.08
-.05
.05
.05
-.06
-.04
.05
.18*
.20*

-.03
-.06
-.04
-.16
-.10
-.03
.01
-.08
-.11
-.05

.05
.16*
.30**
.11
.31**
.16*
-.03
-.06
-.15
.24**

-.26**
.42**
-.26**
.57**
-.24**
.23**
.64**
.57**
.37**
.06

1
-.11
.36**
-.42**
.34**
.07
-.14
-.50**
-.23**
-.18*

-.11
1
.04
.24**
.19
.20*
.36**
.41**
.14
.14

.35**
.04
1
-.20*
.71**
.01
.26**
-.50**
-.31**
.06

-.42**
.24**
-.20*
1
-.14
.13
.33**
.55**
.16*
.16*

.34**
.20*
.71**
-.14
1
.11
-.20*
-.37**
-.32**
.07

.07
.20*
.01
.13
.10
1
.20*
-.04
.19*
.08

-14
.36**
-.26**
.33**
-.20*
.20*
1
.41**
.24**
-.10

-.50**
.41**
-.50**
.55**
-.37**
-.04
.41**
1
.40**
.07

-.23**
.14
-.31**
.16*
-.32**
.19*
.24**
.40**
1
.16

-.03
.20*
-.05
.21**
.12
.38**
.25**
.19*
.11
-.01

-.18*
.14
.06
.16*
.07
.08
-.10
.07
.16
1

.12

.05

.11

-.20*

.16*

.20*

-.03*

.20*

-.05

.21**

.12

.39**

.25*

.20*

.11

1

-.01

Note. **. p < .01 (2-tailed)
*
p < .05 (2-tailed)
QLVI/LVI = Quality of Life Values Inventory/Life Values Inventory
QLVI/LVI Diff = Difference between surrogates’ and patients’ ratings of perceived similarity on end-of-life values
HOS = Health Opinion Survey
TIMPS = Trust in Medical Profession Scale
STAI = State-Trait Anxiety Inventory
IRI = Interpersonal Reactivity Index
CESD = Center for Epidemiological Studies—Depression
DUREL = Duke University Religion Index
CBESS = Communication-Based Emotional Support Scale
Tx Under = Treatment understanding score
Tx Disc. = Prior discussion of treatment preferences
Intervention Score = higher scores indicate stronger preferences for intensive interventions
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Table 5
Means and standard deviations for key study variables, as reported by surrogates.
Range of possible scores

M

SD

Empathy (IRI)

28 - 140

95.17

11.13

Trust in the medical profession (TIMPS)

11 - 55

38.78

6.82

Religiosity (DUREL)

6 - 30

17.29

5.60

Anxiety (STAI-T)

20 - 80

50.80

9.83

COVID-19-related anxiety

1 - 10

7.76

1.00

Desire for autonomy on decisions (HOS)

9 - 81

23.95

5.24

Depression (CESD-R)

20 - 60

23.76

5.88

Emotional support from partner (CBESS)

13 - 65

39.00

4.65

Communication with partner about preferences

1-4

3.04

.75

Self-rated physical health

1-5

3.63

.840

Understanding of treatment options

7 - 35

25.49

5.88

Partner’s reluctance to burden others (RBO)

5 - 15

11.34

2.40

70.02

11.13

Variable

Values similarity to partner (QLVI/LVI)

18 - 90
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Treatment intervention score

0–7

5.63

1.40
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Table 6
Results of the multiple regression analysis using significant correlates to predict accuracy.
TIMPS
DUREL
IRI
RBO
QLVI/LVI
QLVI/LVI Diff

B
.01
.03
.02
.00
.01
.00

SE B
.05
.02
.01
.05
.01
.01

p
.60
.07
.10
.89
.41
.78

QLVI/LVI = Quality of Life Values Inventory/Life Values Inventory
QLVI/LVI Diff = Difference between surrogates’ and patients’ ratings of perceived similarity on end-of-life values
TIMPS = Trust in Medical Profession Scale
RBO = Reluctance to Burden Others Scale
IRI = Interpersonal Reactivity Index
DUREL = Duke University Religion Index
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